Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3046870	s-ttgabg	— (—)	22076	24573	100.00%	Distribution not available
3046870	s-kudostransglutaminaasi,iggvasta-aineet	— (—)	1976	2026	100.00%	Distribution not available
3046870	s-ttgabg	U/ml (u/ml)	273	319	5.02%
3046870	s-kudostransglutaminaasi,iggva(keliakia)	— (—)	127	133	100.00%	Distribution not available
3046870	kudostransglutaminaasi,igg-vasta-aineet	— (—)	121	131	100.00%	Distribution not available
3046870	s-ttgabg	EliAU/ml (u/ml)	24	26	0.00%
3046870	kudostransglutaminaasi,iggvasta-aineet	— (—)	14	15	100.00%	Distribution not available
3046870	s-ttgabg	EliA_U/ml (u/ml)	7	7	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Irritable bowel syndrome

1691

6389

2.85

314.05

1.2

1.1

0.96

9.62

u/ml

0.93

Type 1 diabetes, strict definition

809

1992

4.89

309.01

1.3

1.2

1.57

17.66

u/ml

—

Autoimmune diseases

5215

14753

1.85

308.49

1.2

1.1

14.61

3.47

u/ml

1.10

145

Pain in joint

2993

7973

2.42

307.65

1.1

7.31

10.12

u/ml

0.17

104

Type 1 diabetes, strict (exclude DM2)

919

2350

4.62

307.65

1.3

1.2

1.55

16.20

u/ml

—

Insulin, fast-acting

2113

8007

2.84

307.65

1.3

1.1

5.97

10.11

u/ml

0.28

Other diseases of intestines

5127

15702

1.88

307.65

1.1

3.84

12.87

u/ml

1.50

180

Autoimmune diseases excluding thyroid diseases

5145

14622

1.98

307.65

1.2

1.1

17.42

3.47

u/ml

1.40

145

Type 1 diabetes, wide definition

1679

5013

3.74

307.65

1.3

1.1

7.51

12.74

u/ml

0.23

Type 1 diabetes, definitions combined

921

2362

4.60

307.65

1.3

1.2

1.55

16.20

u/ml

—

Insulin, fast-acting or short human

2119

8146

2.79

307.65

1.3

1.1

5.97

12.63

u/ml

0.47

Type 1 diabetes

1793

5654

3.50

307.65

1.3

1.1

7.53

12.14

u/ml

0.21

Anaemias

1484

2688

3.84

307.65

1.2

1.1

7.10

8.75

u/ml

0.09

Autoimmune diseases excluding thyroid diseases, strict definition

4966

14173

1.98

307.65

1.2

1.1

17.83

3.53

u/ml

1.40

142

Type 1 diabetes, wide definition, subgroup 1

1644

4787

3.86

307.65

1.3

1.1

7.93

12.93

u/ml

0.21

Examination and observation for other reasons

3347

7197

2.78

307.65

1.1

8.57

4.67

u/ml

0.43

Sub-endpoint used in defining T1D endpoints

1802

6187

3.10

307.65

1.3

1.1

6.81

11.20

u/ml

0.22

Type 1 diabetes, strict definition, subgroup 1

779

1883

5.00

305.31

1.3

1.2

1.64

19.44

u/ml

—

Insulin, intermediate and long-acting

2644

11837

2.26

305.20

1.2

1.1

17.51

9.81

u/ml

0.26

138

Anxiety (asthma-related co-morbidities)

3285

12376

2.11

304.86

1.1

2.83

6.16

u/ml

0.77

161

Insulin, fast-acting (human)

983

2767

3.97

304.84

1.3

1.1

11.35

1.88

u/ml

—

Depression

4699

17383

1.87

304.81

1.1

13.95

7.98

u/ml

0.31

215

Mood disorders, excluding more controls

4403

14048

1.91

294.06

1.1

15.29

5.97

u/ml

0.50

177

Anxiety disorders, excluding more controls

4017

13627

1.96

293.35

1.1

10.11

5.73

u/ml

0.23

170

Mood [affective] disorders

4898

17737

1.83

292.84

1.1

13.75

7.80

u/ml

0.32

221

Mood disorders

4902

17737

1.83

292.04

1.1

13.75

7.80

u/ml

0.32

221

Used for control exclusion in common control thyroid runs

4862

13659

1.85

287.31

1.2

1.1

15.89

3.78

u/ml

1.05

129

All anxiety disorders

3359

13421

2.03

281.45

1.1

12.03

9.19

u/ml

0.11

175

Other soft tissue disorders, not elsewhere classified

4456

14075

1.86

274.95

1.1

2.48

10.64

u/ml

1.63

172

Pain in limb

3994

13770

1.91

272.44

1.1

2.30

10.88

u/ml

1.68

167

Other functional intestinal disorders

2305

9619

2.28

269.55

1.2

1.1

2.56

10.85

u/ml

0.98

103

Neurotic, stress-related and somatoform disorders

4381

17034

1.84

268.10

1.1

9.49

7.91

u/ml

0.08

214

Pure hypercholesterolaemia

3281

10653

2.03

266.35

1.1

12.69

5.98

u/ml

0.28

137

Anxiety disorders

4404

17110

1.83

266.22

1.1

9.31

7.91

u/ml

0.07

214

Constipation

4115

15606

1.85

257.42

1.1

4.05

9.49

u/ml

0.76

177

Insulin, combination of fast acting with intermediate-acting or long-acting

2799

12830

2.06

253.50

1.2

1.1

14.73

9.47

u/ml

0.21

144

Intestinal infectious diseases, including avohilmo, including avohilmo

5263

17457

1.73

253.41

1.1

13.86

8.27

u/ml

0.29

223

Low back pain

3684

13550

1.90

251.12

1.1

7.28

5.52

u/ml

0.11

165

Headache

3348

13829

1.94

249.44

1.1

7.80

10.30

u/ml

0.14

158

Insulin medication

2799

11765

2.06

247.85

1.2

1.1

14.73

8.09

u/ml

0.27

135

Other anxiety disorders

2593

10952

2.12

245.90

1.1

18.58

8.17

u/ml

0.39

144

Diverticular disease of intestine

2889

9067

2.05

242.31

1.1

0.92

11.93

u/ml

1.58

103

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4492

17734

1.76

239.84

1.2

1.1

22.69

5.72

u/ml

1.11

200

Metabolic disorders

4188

14326

1.81

239.31

1.1

14.79

5.37

u/ml

0.51

178

Disorders of lipoprotein metabolism and other lipidaemias

3500

11490

1.91

239.20

1.1

11.64

5.79

u/ml

0.27

148

Endocrine, nutritional and metabolic diseases

3695

10151

1.90

235.44

1.2

1.1

3.00

11.49

u/ml

1.14

119

Diseases of oesophagus, stomach and duodenum

4753

16648

1.74

235.27

1.1

6.17

9.59

u/ml

0.31

190

Dorsalgia

4478

13961

1.75

222.74

1.1

7.63

5.42

u/ml

0.16

169

Lower back pain or/and sciatica

4848

18352

1.69

219.92

1.1

6.19

8.66

u/ml

0.21

214

Other antidepressants

4366

13041

1.76

219.09

1.1

6.49

11.04

u/ml

0.35

153

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

4617

17884

1.70

217.60

1.1

14.84

8.11

u/ml

0.34

228

Care involving use of rehabilitation procedures

3053

15192

1.88

209.87

1.2

1.1

12.10

6.41

u/ml

0.21

176

Tramadol

3443

11611

1.84

207.95

1.1

12.53

4.91

u/ml

0.44

147

Coeliac disease

858

2853

3.37

205.47

1.5

1.1

49.99

0.98

u/ml

2.55

Other specific joint derangements/joint disorders

3552

12630

1.81

205.13

1.1

6.31

13.89

u/ml

0.63

149

Abdominal and pelvic pain

4234

12561

1.74

204.31

1.1

9.62

11.90

u/ml

0.11

163

Symptoms and signs involving the digestive system and abdomen

4239

12566

1.74

203.53

1.1

2.68

11.90

u/ml

1.69

163

Depression or dysthymia

2792

8054

1.95

198.58

1.1

18.71

5.00

u/ml

0.63

Depression medications

1409

2796

2.65

196.85

1.2

1.1

3.20

7.63

u/ml

0.51

Hypothyroidism (congenital or acquired)

1258

2686

2.75

194.71

1.2

1.1

17.59

8.26

u/ml

0.25

Recurrent or chronic depression

1892

6239

2.19

191.56

1.1

11.69

4.80

u/ml

0.28

Personality disorders, excluding more controls

1348

5755

2.48

191.26

1.1

1.26

5.48

u/ml

0.84

Hypothyroidism, levothyroxine purchases

1239

2676

2.72

188.04

1.2

1.1

18.64

8.26

u/ml

0.26

Hypothyroidism and >3 levothyroxin purchases

1239

2676

2.72

188.04

1.2

1.1

18.64

8.26

u/ml

0.26

Other dorsopathies, not elsewhere classified

4395

14020

1.67

185.23

1.1

8.10

7.27

u/ml

0.04

170

Gastrointestinal diseases

2646

6992

1.96

184.94

1.2

1.1

3.15

1.45

u/ml

0.79

Pain in throat and chest

3748

13253

1.72

181.03

1.1

2.07

8.83

u/ml

1.47

167

Other intervertebral disc disorders

3402

11934

1.75

173.77

1.1

1.98

5.11

u/ml

0.82

139

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

4038

14763

1.67

173.24

1.2

1.1

14.66

7.04

u/ml

0.43

183

Pain (limb, back, neck, head abdominally)

2919

8160

1.84

170.97

1.1

14.61

10.03

u/ml

0.15

105

General symptoms and signs

4584

14508

1.62

170.85

1.1

8.76

10.27

u/ml

0.09

167

Asthma (mode)

3399

10483

1.75

170.34

1.1

16.52

5.06

u/ml

0.59

137

Gastro-oesophageal reflux disease

2899

14134

1.78

169.34

1.1

1.39

7.51

u/ml

1.41

155

Diseases of the digestive system

1977

10190

2.00

168.44

1.3

1.1

36.21

1.27

u/ml

2.47

Codeine

3994

13326

1.66

166.51

1.1

2.07

6.70

u/ml

1.26

179

Other and unspecified iron deficiency

1624

7939

2.14

164.56

1.1

1.96

4.83

u/ml

0.47

Asthma

3405

10433

1.73

162.78

1.1

16.52

5.09

u/ml

0.59

136

Other headache syndromes

2038

10802

1.96

162.46

1.1

1.24

7.91

u/ml

1.58

115

Asthma, excluding more controls

3303

10061

1.73

158.58

1.1

17.25

5.14

u/ml

0.60

132

Follow-up examination after treatment for conditions other than malignant neoplasms

1879

6343

2.04

158.16

1.1

1.26

5.09

u/ml

1.24

Selective serotonin reuptake inhibitors

4061

13239

1.63

157.23

1.1

1.94

13.05

u/ml

2.09

154

Soft tissue disorders

4350

14199

1.61

157.06

1.1

6.29

10.48

u/ml

0.35

175

Codeine or tramadol medication

4698

16613

1.57

156.71

1.1

2.62

9.91

u/ml

1.76

214

Other and unspecified anaemias

1736

8288

2.04

155.47

1.1

6.90

7.62

u/ml

0.04

Diabetes, insulin treatment (Kela reimbursement)

4181

15877

1.61

155.39

1.2

1.1

14.37

6.84

u/ml

0.44

191

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4710

16320

1.57

155.29

1.1

3.82

10.64

u/ml

1.24

215

Diabetes mellitus

4410

16454

1.59

154.48

1.2

1.1

9.38

8.89

u/ml

0.03

210

Diabetes medication

4467

16939

1.58

153.45

1.2

1.1

9.02

8.59

u/ml

0.02

218

Other anaemias

1747

8372

2.03

153.38

1.1

6.90

7.62

u/ml

0.04

Exposure to unspecified factor

4437

19736

1.57

151.99

1.1

17.79

7.46

u/ml

0.49

248

Hypothyroidism, drug reimbursement

695

1589

3.24

151.24

1.2

1.1

1.12

8.68

u/ml

—

Sciatica+with lumbago

2200

10765

1.87

151.12

1.1

8.83

5.37

u/ml

0.20

129

Any mental disorder

4435

14344

1.58

150.45

1.1

10.55

5.92

u/ml

0.27

179

Intestinal infectious diseases

4098

19770

1.58

147.73

1.2

1.1

16.40

7.74

u/ml

0.43

242

Nutritional anaemias

2122

11243

1.86

145.24

1.1

1.91

9.34

u/ml

1.11

124

Diseases of liver

1516

7599

2.09

144.11

1.1

4.32

8.72

u/ml

—

Diabetes, varying definitions

4344

16475

1.56

144.09

1.2

1.1

9.77

8.79

u/ml

0.05

211

Other special examinations and investigations of persons without complaint or reported diagnosis

2526

7216

1.82

143.25

1.1

12.83

4.67

u/ml

0.42

Dermatitis and eczema

4735

18730

1.53

142.74

1.1

5.92

10.07

u/ml

0.42

219

Symptoms and signs involving cognition, perception, emotional state and behaviour

4047

17561

1.58

142.53

1.1

9.89

8.25

u/ml

0.07

219

Asthma (diagnoses ohter than nonallergic)

3801

19820

1.59

142.31

1.1

15.56

7.96

u/ml

0.37

235

Autoimmune diseases related-to ILD

3623

19369

1.60

141.41

1.2

1.1

18.04

6.85

u/ml

0.73

223

Symptoms and signs involving the circulatory and respiratory systems

4244

13801

1.58

141.09

1.1

13.25

8.56

u/ml

0.26

173

Aplastic and other anaemias

1837

8988

1.94

141.07

1.1

6.59

10.41

u/ml

0.23

107

Benign neoplasm of colon, rectum, anus and anal canal

2424

11897

1.77

139.50

1.1

2.98

8.36

u/ml

0.74

134

Medical observation and evaluation for suspected diseases and conditions

2492

7216

1.81

139.50

1.1

15.06

4.67

u/ml

0.59

Nonorganic sleeping disorders, excluding more controls

1052

4641

2.40

139.41

1.1

34.99

4.81

u/ml

—

Nerve, nerve root and plexus disorders

4299

17014

1.55

138.57

1.1

11.15

7.20

u/ml

0.24

199

Neurological diseases, wide definition

1366

3157

2.25

137.18

1.2

1.1

1.03

16.63

u/ml

1.05

Asthma, unspecified (mode), excluding more controls

2313

9462

1.80

136.47

1.1

14.60

5.16

u/ml

0.39

124

Asthma (only as main-diagnosis), excluding more controls

3006

10061

1.70

136.30

1.1

15.82

5.14

u/ml

0.57

132

Functional dyspepsia

1280

6170

2.18

135.80

1.2

1.1

2.66

6.25

u/ml

0.33

Shoulder lesions

2862

10305

1.71

135.39

1.1

2.23

9.74

u/ml

1.25

132

Symptoms and signs involving the skin and subcutaneous tissue

3108

18407

1.64

135.38

1.1

10.26

6.99

u/ml

0.16

219

Asthma (only as main-diagnosis)

3061

10433

1.68

135.29

1.1

15.82

5.09

u/ml

0.57

136

Iron deficiency anaemia

1857

9957

1.90

135.11

1.1

1.76

10.17

u/ml

1.07

106

Migraine

2550

11788

1.74

134.30

1.1

1.13

11.72

u/ml

2.06

137

Asthma, unspecified (mode)

2351

9815

1.78

133.27

1.1

14.08

5.14

u/ml

0.38

127

Disease of hard tissues of teeth, NOS

2008

5666

1.91

132.95

1.1

25.03

6.28

u/ml

0.58

Disorders of thyroid, IBD co-morbidities

807

2107

2.75

132.60

1.2

1.1

2.97

8.47

u/ml

—

Abnormalities of breathing

3739

13771

1.59

132.50

1.1

18.50

8.56

u/ml

0.56

173

Opioids

4039

13598

1.57

132.38

1.1

13.70

6.61

u/ml

0.39

182

Chronic rhinitis, nasopharyngitis and pharyngitis

1557

8129

2.00

131.79

1.1

2.34

11.30

u/ml

0.99

Dorsopathies

4259

14228

1.55

131.71

1.1

12.60

7.19

u/ml

0.29

172

Dental caries

1013

4240

2.35

129.64

1.2

1.1

13.70

7.38

u/ml

—

Caries of enamel

4109

17925

1.54

127.99

1.1

10.95

7.54

u/ml

0.25

220

Asthma, including avohilmo

4931

18647

1.49

127.78

1.1

11.75

8.39

u/ml

0.20

218

Any reimbursement code in KELA

2643

7850

1.74

126.90

1.2

1.1

14.00

8.17

u/ml

0.21

Lumbar disc prolapse

2539

11279

1.71

126.50

1.1

2.00

5.17

u/ml

0.79

135

Other/unspecified dorsalgia

1590

8396

1.94

123.93

1.1

2.64

5.53

u/ml

0.46

Malaise and fatigue

2173

9930

1.77

123.61

1.2

1.1

2.50

8.47

u/ml

0.85

106

Neurological diseases

3594

11639

1.59

122.95

1.1

9.60

11.55

u/ml

0.08

134

Disturbances of skin sensation

1348

6887

2.05

122.09

1.1

28.14

2.39

u/ml

0.54

Diarrhoea and gastroenteritis of presumed infectious origin

3023

17196

1.61

121.91

1.1

19.71

8.03

u/ml

0.49

206

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1477

3685

2.07

121.39

1.1

0.91

14.62

u/ml

1.01

Diaphragmatic hernia

1469

7726

1.98

121.27

1.1

1.36

8.66

u/ml

0.89

Chronic gastritis

1081

5097

2.22

120.85

1.1

3.98

1.81

u/ml

0.60

Other arthrosis

1999

7573

1.82

120.56

1.1

1.36

14.31

u/ml

1.66

Personality disorders

1348

6927

2.05

120.25

1.1

1.26

9.44

u/ml

0.94

Persons encountering health services in other circumstances, wide

4637

16335

1.49

119.62

1.1

2.54

10.64

u/ml

1.85

215

Behavioural syndromes associated with physiological disturbances and physical factors

3997

18246

1.52

118.25

1.1

17.11

6.54

u/ml

0.49

226

Psychiatric diseases

3811

12579

1.55

118.13

1.1

10.38

6.44

u/ml

0.22

154

Disorders of adult personality and behaviour

1413

7429

1.99

117.70

1.1

1.30

9.94

u/ml

1.13

Statin medication

2715

9379

1.67

117.21

1.2

1.1

20.26

6.36

u/ml

0.60

127

Other noninfective gastroenteritis and colitis

1206

6014

2.11

116.82

1.2

1.1

6.30

7.27

u/ml

0.05

Myalgia

1127

5506

2.15

115.27

1.1

1.65

10.40

u/ml

0.87

Any death

711

11488

0.42

114.82

1.1

2.60

9.33

u/ml

0.92

123

Caries of dentine

881

3768

2.35

113.35

1.2

1.1

10.72

8.71

u/ml

—

Benign neoplasm: Colon

1995

10985

1.76

112.61

1.1

3.06

8.87

u/ml

0.73

123

Episodal and paroxysmal disorders

4484

15679

1.48

112.03

1.1

6.48

11.92

u/ml

0.40

176

Noninfective enteritis and colitis

2034

12090

1.74

110.67

1.2

1.1

13.81

7.28

u/ml

0.30

125

Asthma, hospital admission 2, infections

2510

15379

1.63

109.00

1.1

22.21

8.94

u/ml

0.47

175

Asthma-related infections

2510

15379

1.63

109.00

1.1

22.21

8.94

u/ml

0.47

175

ILD medications: immunosuppressive drugs

2723

15768

1.61

108.68

1.1

19.84

7.78

u/ml

0.55

180

Other and unspecified polyneuropathies, also in other diseases

785

3399

2.44

108.62

1.2

1.1

32.64

1.13

u/ml

—

Complications of medical and surgical care

2937

17205

1.57

107.16

1.1

18.17

5.39

u/ml

0.60

208

Abnormal findings on examination of blood, without diagnosis

1723

8902

1.81

106.60

1.2

1.1

25.09

11.16

u/ml

0.36

110

Osteopathies and chondropathies

2325

13157

1.66

106.59

1.1

3.26

8.52

u/ml

0.70

144

Specific personality disorders

1172

5990

2.06

106.40

1.1

1.03

7.85

u/ml

0.70

Other disorders of urethra and urinary system

2888

12952

1.59

106.27

1.1

10.48

9.01

u/ml

0.06

167

Persons encountering health services for examination and investigation

2382

7216

1.69

105.83

1.1

14.88

4.67

u/ml

0.35

Infections, IBD-co-morbidities

607

1582

2.82

105.83

1.1

55.55

12.08

u/ml

—

Spondylopathies

2799

10513

1.61

105.70

1.1

10.46

5.48

u/ml

0.26

128

Persons encountering health services for specific procedures and health care

4434

18316

1.46

105.53

1.1

16.62

7.60

u/ml

0.47

229

Hypothyroidism, strict autoimmune

2860

12068

1.59

104.97

1.1

9.31

1.42

u/ml

0.81

117

Spondylosis

1948

8971

1.74

104.60

1.1

3.73

5.63

u/ml

0.25

111

Polyneuropathies and other disorders of the peripheral nervous system

876

4038

2.28

104.21

1.1

29.44

7.43

u/ml

—

Sleep disorders

3768

17761

1.49

104.07

1.1

10.56

6.57

u/ml

0.19

223

Disorders of eyelid, lacrimal system and orbit

3462

17109

1.51

103.94

1.1

7.41

10.38

u/ml

0.17

199

Other diseases of liver

852

3899

2.31

103.86

1.2

1.1

1.34

9.67

u/ml

—

Polyarthropathies

2607

10588

1.62

102.40

1.1

10.33

14.14

u/ml

0.20

121

Inflammatory bowel disease treatment related agents

4622

18137

1.44

102.37

1.1

19.35

6.86

u/ml

0.82

215

Insomnia

3725

17863

1.48

99.47

1.1

11.33

6.45

u/ml

0.22

228

Other diseases of hard tissues of teeth

1922

5783

1.76

99.29

1.1

1.22

6.28

u/ml

0.70

1985

11991

1.69

98.85

1.2

1.1

26.45

8.46

u/ml

0.54

132

Sleep disorders (combined)

4374

16071

1.45

98.83

1.1

9.85

7.14

u/ml

0.12

212

GASTRO-related operations

3314

11055

1.53

98.72

1.1

11.74

10.30

u/ml

0.06

122

Any gastric operation

3314

11055

1.53

98.72

1.1

11.74

10.30

u/ml

0.06

122

Diseases of the eye and adnexa

3248

10815

1.54

97.10

1.2

1.1

10.03

9.87

u/ml

0.01

136

Dysphagia

988

4892

2.10

96.93

1.2

1.1

7.58

10.97

u/ml

0.17

Hyperkinetic disorders, excluding more controls

746

3096

2.39

96.40

1.2

1.12

7.58

u/ml

—

Diseases of the skin and subcutaneous tissue

3861

13352

1.48

96.27

1.1

14.94

8.61

u/ml

0.28

153

ILD medications

4569

17563

1.43

96.12

1.1

18.65

7.07

u/ml

0.77

208

Generalized anxiety disorder

891

4278

2.20

95.92

1.1

13.06

6.68

u/ml

—

Hypertension, essential

2883

10652

1.56

95.50

1.1

5.89

3.67

u/ml

0.30

128

Parasetamol

2873

9458

1.57

94.19

1.1

14.46

7.86

u/ml

0.22

109

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2380

14997

1.60

93.98

1.1

23.25

3.46

u/ml

0.77

174

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1205

6387

1.93

93.23

1.1

4.17

4.42

u/ml

—

Chronic lower respiratory diseases

4854

18520

1.40

92.75

1.1

18.82

5.94

u/ml

0.88

219

Fall on same level

4640

17796

1.41

92.65

1.1

10.56

9.18

u/ml

0.07

221

Visual disturbances

2032

12667

1.65

92.30

1.1

27.06

6.56

u/ml

0.61

132

Other diseases of urinary system

3840

15042

1.46

91.99

1.1

9.21

10.58

u/ml

0.06

189

Symptoms and signs concerning food and fluid intake

556

2224

2.67

91.97

1.2

1.1

1.09

20.13

u/ml

—

Pain, not elsewhere classified

1231

6695

1.91

91.67

1.2

1.1

2.62

5.85

u/ml

0.39

Gingivitis and periodontal diseases

3723

13304

1.47

91.58

1.1

1.94

8.46

u/ml

1.37

169

Other joint disorders

3586

12863

1.48

91.32

1.1

6.61

13.73

u/ml

0.60

151

Disorders of the thyroid gland

3725

16900

1.46

90.68

1.1

7.34

9.33

u/ml

0.16

189

Nausea and vomiting

1155

6018

1.94

90.41

1.2

1.1

2.22

15.37

u/ml

1.03

Cough

1697

9450

1.73

90.24

1.1

13.26

7.50

u/ml

0.22

116

Nonorganic sleeping disorders

1052

5484

2.01

90.17

1.1

34.99

2.62

u/ml

—

Other systemic involvement of connective tissue (FG)

1100

5694

1.97

90.07

1.2

1.1

1.46

1.96

u/ml

0.39

Rotator cuff syndrome

2155

9274

1.64

90.01

1.1

1.85

10.26

u/ml

1.32

122

Diseases of oral cavity, salivary glands and jaws

1891

5796

1.72

89.49

1.1

1.20

6.28

u/ml

0.70

Cystitis

3363

13718

1.49

89.47

1.1

10.26

9.06

u/ml

0.05

176

Diseases of the musculoskeletal system and connective tissue

2238

6985

1.64

88.98

1.2

1.1

3.46

11.42

u/ml

0.90

Special screening examination for infectious and parasitic diseases

1047

3892

2.03

88.88

1.1

4.02

4.64

u/ml

—

Other disorders of lacrimal gland

1546

9085

1.76

88.60

1.2

1.1

14.38

7.20

u/ml

0.22

105

Dizziness and giddiness

2876

15062

1.52

87.93

1.1

14.89

7.15

u/ml

0.26

190

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3572

16859

1.46

87.71

1.1

12.06

7.71

u/ml

0.20

199

Complications of surgical and medical care, not elsewhere classified

3846

18185

1.44

87.39

1.1

14.62

6.70

u/ml

0.42

219

Falls/tendency to fall

4273

15319

1.42

86.88

1.1

10.38

9.83

u/ml

0.02

200

Hypothyroidism, other/unspecified

3516

16137

1.46

86.83

1.1

8.32

7.59

u/ml

0.05

186

Other symptoms and signs involving cognitive functions and awareness

1704

9088

1.71

86.81

1.1

1.20

4.31

u/ml

0.83

116

Certain infectious and parasitic diseases

3889

13713

1.45

86.80

1.1

19.41

5.50

u/ml

0.62

166

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2198

14107

1.59

86.72

1.1

12.47

5.50

u/ml

0.36

167

Asthma, hospital admissions , main diagnosis only

3327

20170

1.46

86.71

1.1

14.94

7.68

u/ml

0.37

234

Visual disturbances and blindness

2130

13607

1.61

86.65

1.1

25.98

6.17

u/ml

0.61

142

Hypertensive diseases (excluding secondary)

2113

7671

1.64

86.43

1.1

19.70

4.99

u/ml

0.51

Use of hypnotics and sedatives

4020

16366

1.43

86.21

1.1

1.53

10.16

u/ml

2.22

199

Other reaction to severe stress, and adjustment disorders

1600

9555

1.73

85.91

1.2

1.1

33.59

4.23

u/ml

0.56

124

ILD medications: prednisolone, methylprednisolone, prednisone

4265

17075

1.41

85.30

1.1

20.59

7.15

u/ml

0.83

205

Hypothyreosis and Thyroxine purchase for inclusion criteria

3642

16814

1.45

85.30

1.1

8.07

7.22

u/ml

0.06

197

Subjective visual disturbances

1137

6186

1.92

85.23

1.2

1.1

21.74

7.05

u/ml

0.30

Osteoporosis

1089

5339

1.95

85.20

1.2

1.1

4.99

1.70

u/ml

0.36

Disorders of conjunctiva

3518

19201

1.45

85.18

1.1

16.35

8.05

u/ml

0.35

230

Disorders of synovium and tendon

2065

11096

1.62

84.79

1.1

8.91

9.66

u/ml

0.03

137

Disorders of lacrimal system

1808

11059

1.66

82.76

1.2

1.1

11.53

6.20

u/ml

0.21

134

Migraine with aura

1237

6995

1.84

81.57

1.1

0.96

6.61

u/ml

1.34

Somatoform disorder

754

3625

2.19

81.12

1.2

1.1

0.90

2.56

u/ml

1.34

Chronic sinusitis

1693

10407

1.67

80.77

1.2

1.1

34.36

7.45

u/ml

—

131

Oral corticosteroids

4056

17192

1.41

80.14

1.1

19.14

5.49

u/ml

0.86

209

Complications of procedures, not elsewhere classified

3106

17439

1.46

79.99

1.1

8.83

6.76

u/ml

0.13

210

Other diseases of upper respiratory tract

4206

15913

1.40

79.08

1.1

2.80

8.30

u/ml

1.10

206

Collagenous colitis

476

1915

2.68

78.73

1.2

1.1

14.58

1.41

u/ml

—

Voice disturbances

1120

6214

1.88

78.73

1.2

1.1

20.37

2.02

u/ml

0.45

Conjunctivitis

3245

18430

1.45

78.57

1.1

17.62

8.23

u/ml

0.37

220

Oedema, not elsewhere classified

1242

6923

1.81

78.17

1.1

1.26

5.26

u/ml

0.67

Mycoses, including avohilmo

3662

20084

1.41

77.54

1.1

6.14

8.22

u/ml

0.21

249

Dermatitis

2433

16012

1.52

77.52

1.1

8.80

9.86

u/ml

0.05

189

Other pulmonary diagnosis

3050

10516

1.48

76.89

1.1

12.28

5.00

u/ml

0.32

139

Soft tissue disorders related to use, overuse and pressure

1040

5673

1.90

76.60

1.1

0.99

10.04

u/ml

0.97

Persons encountering health services for specific procedures, not carried out

458

1832

2.69

76.47

1.2

1.1

6.90

2.27

u/ml

—

Arthropathies

3601

12939

1.43

76.22

1.1

8.43

13.73

u/ml

0.38

151

Symptoms and signs involving speech and voice

1328

7804

1.76

76.16

1.2

1.1

17.22

8.28

u/ml

0.22

Other nutritional deficiencies

2756

17398

1.48

76.05

1.1

8.28

8.87

u/ml

0.03

211

Excluding asthma or asthma-COPD overlap

3043

10516

1.48

75.82

1.1

12.63

5.00

u/ml

0.33

139

Phobic anxiety disorders

704

3379

2.20

75.81

1.2

1.1

13.63

2.32

u/ml

—

Certain infectious and parasitic diseases, including avohilmo

2681

9031

1.51

75.73

1.1

14.75

2.90

u/ml

0.47

115

Hypertension

2898

11230

1.48

75.54

1.1

15.05

3.56

u/ml

0.61

133

Hypertensive diseases

2898

11247

1.48

75.02

1.1

15.05

3.56

u/ml

0.61

133

Implicit viral Sepsis, including avohilmo

1198

6848

1.80

74.99

1.1

36.48

5.80

u/ml

0.53

Other and unspecified dermatitis

2082

13676

1.56

74.99

1.1

10.06

8.83

u/ml

0.05

145

Atopic dermatitis

2588

14064

1.50

74.91

1.1

2.61

12.44

u/ml

1.78

163

ILD differential diagnosis

3029

10483

1.47

74.91

1.1

12.63

5.06

u/ml

0.33

137

COPD differential diagnosis

3030

10490

1.47

74.83

1.1

12.63

5.06

u/ml

0.33

137

Cardiovascular diseases

2722

9811

1.51

74.81

1.2

1.1

19.45

7.55

u/ml

0.52

111

Systemic connective tissue disorders

1399

8383

1.72

74.61

1.2

1.1

1.41

1.72

u/ml

0.31

KRA_PSY_EATING, excluding more controls

493

2047

2.57

74.46

1.2

1.1

36.34

1.57

u/ml

—

Finngen Rheumatological endpoints

3706

15161

1.41

74.23

1.1

6.00

12.04

u/ml

0.55

186

Implicit Sepsis, including avohilmo

3113

15681

1.44

73.81

1.1

11.80

8.24

u/ml

0.17

179

Cervicobrachial syndrome

884

4640

1.98

73.64

1.2

1.1

0.94

6.67

u/ml

0.80

First line medication for Crohn's disease

4338

17257

1.37

73.39

1.1

18.63

7.29

u/ml

0.74

201

Benzodiazepine use

3860

19043

1.39

73.24

1.1

7.57

8.22

u/ml

0.03

237

Provisional assignment of new diseases of uncertain etiology

2099

13764

1.55

73.11

1.1

21.40

5.52

u/ml

0.70

153

Cardiac arrhythmias

2370

10150

1.53

73.05

1.1

14.66

7.09

u/ml

0.33

117

Codes for special purposes

2099

13776

1.55

72.77

1.1

21.40

5.52

u/ml

0.70

153

Injuries to the ankle and foot

3009

18167

1.44

72.66

1.1

9.62

9.73

u/ml

0.01

218

Type 2 diabetes, wide definition

2782

12114

1.48

72.21

1.1

16.74

5.51

u/ml

0.45

156

Diseases of pulp and periapical tissues, including avohilmo

4031

15279

1.39

71.66

1.1

2.39

9.42

u/ml

1.55

203

Other systemic involvement of connective tissue

1117

6374

1.82

71.32

1.2

1.1

1.46

1.88

u/ml

0.35

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1183

5971

1.80

70.94

1.2

33.69

12.24

u/ml

0.32

Panic disorder

737

3698

2.10

70.75

1.2

1.1

20.18

2.24

u/ml

—

Symptoms and signs involving the nervous and musculoskeletal systems

2235

15086

1.52

70.53

1.1

2.35

8.49

u/ml

1.15

162

Temporomandibular joint disorders, including avohilmo

2041

13126

1.55

70.13

1.1

15.86

6.42

u/ml

0.27

164

Acute upper respiratory infections

4026

17823

1.37

70.04

1.1

8.39

6.95

u/ml

0.08

209

Missing teeth due to accident, extraction or parodontitis

2203

13214

1.52

70.04

1.1

14.94

7.62

u/ml

0.24

158

Antihypertensive medication - note that there are other indications

2672

9569

1.49

69.89

1.2

1.1

23.29

9.16

u/ml

0.51

115

Spinal stenosis

1605

7353

1.64

69.50

1.1

6.34

4.41

u/ml

0.18

Conjunctivitis (acute, non atopic), including avohilmo

3888

17292

1.38

69.06

1.1

1.44

8.98

u/ml

2.34

212

Other bacterial intestinal infections, including avohilmo

920

4997

1.91

68.97

1.1

1.67

2.02

u/ml

—

Dental operations

1937

6378

1.59

68.67

1.1

1.24

9.75

u/ml

0.93

Dentofacial anomalies [including malocclusion]

2965

16498

1.44

68.51

1.1

9.41

7.69

u/ml

0.07

192

Condition for Implicit Sepsis (Organ dysfunction codes)

3214

15995

1.42

68.15

1.1

11.81

8.08

u/ml

0.17

183

Haemorrhoids and perianal venous thrombosis

1162

6722

1.76

67.98

1.1

2.20

9.24

u/ml

0.74

Migraine without aura

1020

5762

1.85

67.86

1.1

1.21

13.22

u/ml

—

Covid-19 confirmed case

1385

8467

1.68

67.68

1.1

39.41

4.74

u/ml

0.74

Noninfectious colitis NAS

618

2959

2.20

67.36

1.2

1.1

1.09

2.04

u/ml

—

Type 2 diabetes

3583

15123

1.39

67.19

1.1

10.18

7.59

u/ml

0.14

194

Post-traumatic stress disorder

491

2152

2.44

67.18

1.2

1.1

7.96

2.55

u/ml

—

Implicit Sepsis

2774

14372

1.45

67.14

1.1

12.63

8.28

u/ml

0.19

160

Emotionally unstable personality disorder

645

3151

2.17

67.14

1.2

1.1

0.99

3.21

u/ml

—

Obesity related asthma

1340

8165

1.69

66.92

1.1

19.12

4.83

u/ml

0.35

Unspecified mental disorder

1579

10022

1.62

66.50

1.1

1.34

9.66

u/ml

1.44

116

Chronic apical periodontitis

4244

17881

1.35

65.23

1.1

4.39

8.41

u/ml

0.61

233

Other external causes of accidental injury

3043

10814

1.43

65.22

1.1

14.43

8.45

u/ml

0.22

151

Candidiasis, including avohilmo

1319

8087

1.69

64.69

1.1

1.69

5.81

u/ml

0.54

Asthma/COPD (KELA code 203)

3724

18490

1.37

63.67

1.1

7.96

5.94

u/ml

0.13

219

Abnormal serum enzyme levels

928

4981

1.85

63.57

1.2

1.1

35.43

12.88

u/ml

—

Bipolar affective disorders

797

4252

1.95

63.54

1.1

0.83

1.59

u/ml

—

Other gastritis (incl. Duodenitis)

791

4204

1.95

63.38

1.1

4.38

9.19

u/ml

—

Other retinal disorders

2199

11391

1.50

63.10

1.2

1.1

6.21

6.74

u/ml

0.03

136

Diseases of pulp and periapical tissues and dental caries

2213

7632

1.51

62.85

1.1

1.85

10.31

u/ml

1.15

107

Abnormalities of heart beat

1352

8115

1.66

62.73

1.1

1.41

4.80

u/ml

0.68

Dyspnoea

3337

17687

1.38

62.32

1.1

14.59

5.99

u/ml

0.53

199

Weight loss

478

2141

2.38

62.02

1.2

1.1

1.15

1.33

u/ml

—

General examination and investigation of persons without complaint and reported diagnosis

2084

7212

1.53

61.81

1.1

11.59

4.67

u/ml

0.35

Pain in thoracic spine

644

3227

2.08

61.73

1.1

1.04

2.71

u/ml

—

Dental caries, including avohilmo

2448

8641

1.47

61.35

1.1

1.69

9.50

u/ml

1.16

117

Non-selective monoamine reuptake inhibitors

1281

7554

1.67

61.06

1.1

1.13

10.10

u/ml

1.10

4307

16552

1.34

60.99

1.1

7.48

7.35

u/ml

0.01

188

Second line medication for Crohn's disease

2240

15576

1.47

60.50

1.1

11.67

10.05

u/ml

0.08

170

Urinary track infection

2663

9390

1.45

60.45

1.1

14.91

6.62

u/ml

0.30

128

Heartburn

475

2139

2.33

60.20

1.2

1.1

0.89

2.54

u/ml

—

Disorders of gallbladder, biliary tract and pancreas

3533

16331

1.37

59.75

1.1

7.98

7.34

u/ml

0.04

190

Obesity, other/unspecified

1411

8960

1.62

59.70

1.1

1.74

9.77

u/ml

1.16

104

Persistent mood disorders

771

4151

1.93

59.69

1.1

1.28

1.70

u/ml

—

Other specified/unspecified arthritis

1023

5981

1.76

59.69

1.1

0.91

11.46

u/ml

1.09

Factors influencing health status and contact with health services

934

2553

1.87

59.25

1.1

0.81

7.37

u/ml

—

Schizophrenia or delusion, excluding more controls

1085

6372

1.73

59.08

1.1

1.16

8.55

u/ml

1.17

Cervical disc disorders

1188

7240

1.68

58.92

1.1

22.64

5.48

u/ml

0.35

Other diseases of lip and oral mucosa

1643

10829

1.56

58.70

1.1

1.09

7.27

u/ml

1.17

123

Allergic asthma (mode), excluding more controls

1019

5831

1.76

58.69

1.2

1.1

25.58

6.19

u/ml

0.37

Allergic asthma (mode)

1019

5846

1.76

58.18

1.2

1.1

25.58

6.33

u/ml

0.37

Dental pulpitis, including avohilmo

3597

17259

1.36

58.03

1.1

5.68

9.20

u/ml

0.39

216

Acute upper respiratory infections of multiple and unspecified sites

2978

15864

1.39

57.84

1.2

1.1

18.97

7.47

u/ml

0.49

181

Other arrhythmias

2431

12826

1.44

57.68

1.1

12.57

6.00

u/ml

0.25

139

Caries of dentine, including avohilmo

2701

9809

1.43

57.63

1.1

2.04

12.00

u/ml

1.49

130

Other disorders of skin and subcutaneous tissue

2623

15906

1.42

57.52

1.2

1.1

15.72

6.48

u/ml

0.41

180

Carpal tunnel syndrome

2199

13290

1.46

57.34

1.1

14.52

6.57

u/ml

0.39

156

Cardiovascular diseases (excluding rheumatic etc)

2693

11010

1.43

57.33

1.2

1.1

19.64

9.21

u/ml

0.44

125

Cervicalgia

779

4264

1.89

57.02

1.1

1.33

6.51

u/ml

0.61

Trochanteric bursitis

606

3060

2.07

57.01

1.1

0.88

2.05

u/ml

1.46

Accidents

2982

10814

1.40

56.90

1.1

14.89

8.45

u/ml

0.23

151

Viral and other specified intestinal infections, including avohilmo

1270

7657

1.64

56.57

1.2

1.1

1.04

9.81

u/ml

1.30

Diabetic maculopathy, excluding more controls

428

1897

2.37

56.40

1.2

1.1

20.52

1.24

u/ml

—

Mixed and other personality disorders

387

1656

2.50

55.98

1.1

1.90

0.87

u/ml

—

Other diseases of anus and rectum

1004

5912

1.74

55.92

1.1

1.08

10.30

u/ml

0.98

Disturbance of activity and attention

752

4030

1.92

55.44

1.2

1.12

2.28

u/ml

—

Disorders of choroid and retina

2738

13897

1.40

55.11

1.2

1.1

5.33

7.69

u/ml

0.20

172

Genitourinary diseases

1995

6765

1.50

55.04

1.2

1.1

32.50

14.20

u/ml

0.41

Reimbursement for rheumatic diseases

2126

14835

1.45

54.73

1.1

7.22

8.65

u/ml

0.08

156

Benign neoplasms

3644

14949

1.34

54.49

1.1

17.24

7.82

u/ml

0.47

171

L04AX Other immunosuppressants

2144

15089

1.45

54.43

1.1

11.62

10.64

u/ml

0.04

160

Pain and other conditions associated with female genital organs and menstrual cycle

996

4941

1.75

54.08

1.2

1.1

2.09

7.58

u/ml

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

3483

20533

1.34

53.77

1.1

21.71

7.32

u/ml

0.62

256

Substance abuse, excluding more controls

1825

10374

1.50

53.72

1.1

19.88

6.66

u/ml

0.45

129

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1271

7999

1.62

53.44

1.1

9.02

11.90

u/ml

0.11

Other arthritis (FG)

1153

7159

1.66

53.42

1.1

0.96

9.30

u/ml

1.04

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1841

12177

1.49

53.24

1.1

1.20

8.40

u/ml

1.56

156

COPD/asthma/ILD related infections

3869

14766

1.33

52.96

1.1

8.72

6.83

u/ml

0.11

169

COPD/asthma related infections

3869

14766

1.33

52.96

1.1

8.72

6.83

u/ml

0.11

169

Other enthesopathies

1067

6508

1.68

52.92

1.1

1.23

9.95

u/ml

1.13

Asthma-related pneumonia

1284

8192

1.60

52.05

1.1

35.49

8.38

u/ml

—

Disorders of other endocrine glands

1760

11860

1.50

52.01

1.2

1.1

1.50

11.05

u/ml

1.46

123

Haemorrhage from respiratory passages

1121

6119

1.66

51.97

1.1

2.14

10.68

u/ml

0.96

Asthma-related pneumonia or sepsis

1287

8223

1.60

51.83

1.1

35.49

8.38

u/ml

—

Asthma, hospital admissions 3, pneumonia

1287

8223

1.60

51.83

1.1

35.49

8.38

u/ml

—

Obsessive-compulsive disorder

378

1657

2.44

51.81

1.2

2.98

2.48

u/ml

—

Bronchitis

4111

19086

1.31

51.73

1.1

13.32

6.61

u/ml

0.41

226

Speech and linguistic disorders, excluding more controls

430

1859

2.30

51.47

1.2

3.36

2.37

u/ml

—

Hyperkinetic disorders

785

4364

1.84

51.13

1.2

1.12

11.86

u/ml

—

All kidney diseases

3694

19016

1.32

50.10

1.1

18.06

8.06

u/ml

0.49

226

Deforming dorsopathies

1048

6457

1.67

50.09

1.2

1.1

14.29

5.86

u/ml

0.35

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2275

15746

1.41

49.51

1.1

1.18

5.83

u/ml

1.58

198

Social phobias

439

2082

2.23

49.39

1.2

1.1

20.20

2.62

u/ml

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1474

9701

1.53

49.19

1.2

1.1

6.05

7.60

u/ml

0.09

109

Excessive attrition of teeth

2388

17265

1.39

48.75

1.1

2.09

10.36

u/ml

1.93

201

Rheumatism, unspecified

542

2784

2.04

48.74

1.2

1.1

1.51

2.12

u/ml

—

Irregular menses

2166

11643

1.43

48.63

1.1

15.18

3.81

u/ml

0.84

147

Hypothyroidism, strict autoimmune, 3 medication purchases required

3131

15876

1.35

48.54

1.1

8.69

7.78

u/ml

0.06

180

External causes of morbidity and mortality

2444

8814

1.41

48.46

1.1

2.57

8.49

u/ml

1.07

124

3328

14766

1.34

48.23

1.1

18.74

6.83

u/ml

0.51

169

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3328

14766

1.34

48.23

1.1

18.74

6.83

u/ml

0.51

169

Arthrosis

2272

8882

1.42

48.04

1.1

1.08

12.87

u/ml

1.81

106

Allergic conjunctivitis

2370

16675

1.39

48.00

1.1

17.21

6.70

u/ml

0.28

211

Exposure to other specified factors

3083

20103

1.34

47.38

1.1

2.70

10.12

u/ml

1.87

249

Other extrapyramidal and movement disorders in other diseases

901

5428

1.71

47.34

1.1

2.20

1.64

u/ml

—

Poisoning by drugs, medicaments and biological substances

975

6000

1.68

47.28

1.2

1.1

5.47

7.80

u/ml

—

Obesity and other hyperalimentation

2450

16967

1.38

47.06

1.1

1.44

10.07

u/ml

2.25

203

Extrapyramidal and movement disorders

1311

8630

1.56

47.05

1.1

1.65

7.73

u/ml

0.87

101

Diseases of the ear and mastoid process

4287

16856

1.29

47.00

1.1

8.10

7.20

u/ml

0.07

191

Undetermined asthma, excluding more controls

531

2736

2.02

46.97

1.1

50.62

1.52

u/ml

—

Obesity

2440

16920

1.38

46.93

1.1

1.44

10.12

u/ml

2.25

202

Rheumatoid arthritis

1077

5982

1.63

46.80

1.1

14.17

9.97

u/ml

0.11

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1205

7812

1.59

46.77

1.1

4.17

9.19

u/ml

—

Infections of the skin and subcutaneous tissue

2191

15645

1.40

46.45

1.2

1.1

14.49

9.18

u/ml

0.24

177

Undetermined asthma

531

2748

2.01

46.38

1.1

50.62

1.54

u/ml

—

Implicit viral Sepsis

765

4437

1.78

46.17

1.2

1.1

55.55

7.00

u/ml

—

Viral Sepsis

765

4446

1.78

45.84

1.2

1.1

55.55

7.00

u/ml

—

Sleep apnoea, including avohilmo

3531

16479

1.31

45.59

1.1

9.18

6.90

u/ml

0.11

200

Adhesive capsulitis of shoulder

581

3120

1.93

45.36

1.1

1.12

16.31

u/ml

—

Periodontitis

3489

17192

1.31

44.86

1.1

2.61

7.94

u/ml

1.27

213

Syncope and collapse

1527

8686

1.49

44.80

1.1

1.74

6.10

u/ml

0.88

Concussion

1855

10154

1.44

44.52

1.1

2.15

11.06

u/ml

1.46

113

Other and unspecified nerve root and plexus disorders, also in other diseases

764

4484

1.76

44.29

1.2

1.1

7.74

7.34

u/ml

—

Asthma and allergy

616

3364

1.88

43.95

1.2

1.1

1.11

1.86

u/ml

—

Chronic periodontitis, including avohilmo

3475

17183

1.31

43.90

1.1

2.61

7.94

u/ml

1.27

213

Poisoning by medicine

885

5426

1.69

43.66

1.2

1.1

5.47

8.32

u/ml

—

Other heart diseases, wide

3467

16259

1.31

43.54

1.1

18.89

6.95

u/ml

0.72

180

Fracture of lumbar spine and pelvis

754

4416

1.75

43.43

1.2

1.1

11.93

1.50

u/ml

—

L04AA Selective immunosuppressants

869

5314

1.69

43.34

1.2

1.1

55.20

2.20

u/ml

0.97

Asthma and allergy, excluding more controls

616

3383

1.87

43.22

1.2

1.1

1.11

1.86

u/ml

—

Ovarian cyst

1404

5363

1.54

43.15

1.1

1.07

6.41

u/ml

0.67

Budesonide

577

3148

1.91

43.15

1.1

6.03

1.77

u/ml

—

Injuries to the thorax

1500

10312

1.48

43.09

1.1

2.13

9.91

u/ml

1.16

118

Migraine with aura and triptan purchases

770

4583

1.75

42.96

1.1

1.17

8.46

u/ml

—

Need for other prophylactic measures

280

1172

2.57

42.89

1.2

1.1

—

1.75

—

Hernia

3250

16664

1.31

42.71

1.1

1.42

8.40

u/ml

1.91

198

Vasomotor and allergic rhinitis

1520

10281

1.48

42.50

1.2

1.1

14.78

8.93

u/ml

0.16

131

Convulsions, not elsewhere classified

871

5276

1.67

42.39

1.2

1.1

1.29

15.89

u/ml

0.98

Kela-code for severe mental illness

1290

8660

1.52

42.27

1.1

1.28

8.82

u/ml

1.14

Injuries to the knee and lower leg

4433

19188

1.26

41.65

1.1

9.42

9.01

u/ml

0.02

229

Other disorders of fluid, electrolyte and acid-base balance

974

5793

1.62

41.53

1.1

0.92

7.31

u/ml

0.65

Eating disorder

500

2653

2.00

41.43

1.2

36.34

3.80

u/ml

—

Gonarthrosis

1936

7800

1.42

41.40

1.1

1.80

13.88

u/ml

1.61

Coxibs

912

2892

1.69

41.36

1.1

0.91

7.45

u/ml

—

Disorders of tooth development and eruption

603

2715

1.86

41.22

1.1

0.88

1.93

u/ml

—

Atopic dermatitis, strict definition with reimbursement

1305

8486

1.52

41.09

1.2

1.1

1.10

12.33

u/ml

1.43

Excessive, frequent and irregular menstruation

1585

5834

1.48

41.04

1.2

1.1

15.41

6.41

u/ml

0.47

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2183

14011

1.38

41.01

1.1

9.63

7.36

u/ml

0.13

159

Sicca syndrome [Sjögren]

382

1853

2.19

40.87

1.2

1.1

1.77

1.88

u/ml

—

Fever of other and unknown origin

1943

12190

1.40

40.85

1.1

13.95

10.78

u/ml

0.11

133

Disorders of lens

2112

9538

1.39

40.78

1.1

1.37

9.17

u/ml

1.24

121

Intracranial trauma

2089

10302

1.39

40.27

1.1

2.01

10.81

u/ml

1.50

116

Diseases of the respiratory system

2361

8737

1.37

40.14

1.1

2.89

5.06

u/ml

0.38

113

Migraine without aura and triptan purchases

786

4788

1.71

40.13

1.1

1.20

14.04

u/ml

—

STROKE

1811

8709

1.42

39.85

1.1

44.46

3.23

u/ml

0.79

104

Other (not insulin) diabetes medications

3302

15080

1.30

39.84

1.1

15.17

6.11

u/ml

0.44

190

Disorders of vitreous body and globe

1714

11592

1.42

39.60

1.1

5.70

6.73

u/ml

0.08

139

Diseases of salivary glands

1212

8150

1.52

39.60

1.1

2.79

7.79

u/ml

0.55

Abnormal involuntary movements

521

2833

1.91

39.49

1.1

4.86

1.79

u/ml

—

Disorders of skin appendages

1948

14190

1.39

39.44

1.1

15.64

8.94

u/ml

0.31

171

Postprocedural endocrine and metabolic disorders, not elsewhere classified

514

2789

1.92

39.30

1.1

1.18

2.09

u/ml

—

Fall on same level involving ice and snow

2108

15624

1.37

39.24

1.1

1.54

8.94

u/ml

1.81

180

Disorders of vitreous body

1675

11373

1.43

39.21

1.1

5.70

4.43

u/ml

0.11

137

Transport accidents

1679

9953

1.43

38.88

1.2

1.1

4.64

8.98

u/ml

0.58

141

Necrosis of pulp, including avohilmo

2141

15755

1.37

38.67

1.1

13.97

8.09

u/ml

0.32

193

Hernia of abdominal wall, postoperative

618

3519

1.79

38.67

1.1

2.01

10.29

u/ml

—

Unspecified fall

1843

13162

1.40

38.59

1.1

6.11

8.16

u/ml

0.20

145

Cholecystectomy

2401

15394

1.34

38.55

1.1

1.50

5.79

u/ml

1.13

180

Cholelithiasis, broad definition with cholecystitis

2945

15138

1.31

38.54

1.1

1.50

7.42

u/ml

1.53

175

Cholelithiasis

2844

14932

1.32

38.53

1.1

1.53

7.46

u/ml

1.52

174

Implicit bacterial Sepsis, including avohilmo

1438

8298

1.47

38.51

1.1

2.16

5.13

u/ml

0.55

Erosion of teeth , including avohilmo

1083

7163

1.55

38.48

1.2

1.1

1.68

11.14

u/ml

0.87

Papulosquamous disorders

1368

9468

1.48

38.45

1.1

16.65

7.45

u/ml

0.37

107

Non-allergic asthma (mode), excluding more controls

703

4156

1.73

38.25

1.1

0.79

6.77

u/ml

—

Endometriosis

1309

5144

1.52

38.14

1.1

2.05

6.57

u/ml

0.50

Other metabolic disorders

547

3054

1.86

38.11

1.1

1.18

2.04

u/ml

—

Fracture of foot, except ankle

968

6260

1.59

38.09

1.1

0.99

6.80

u/ml

—

Chronic diseases of tonsils and adenoids

2931

14289

1.31

37.96

1.1

9.61

9.64

u/ml

0.00

173

Influenza and pneumonia

3957

19564

1.26

37.88

1.1

13.77

8.26

u/ml

0.28

239

Non-allergic asthma (mode)

703

4170

1.72

37.78

1.1

0.79

6.89

u/ml

—

Sleep apnoea

3226

15919

1.29

37.70

1.1

11.42

6.03

u/ml

0.22

195

Emotional disorders starting during childhood or adolecense, excluding more controls

277

1184

2.45

37.68

1.3

1.2

9.00

2.61

u/ml

—

Other bacterial diseases, including avohilmo

3657

18143

1.27

37.63

1.1

19.07

7.28

u/ml

0.69

204

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1283

8823

1.49

37.52

1.2

1.1

1.19

5.06

u/ml

0.63

101

Thyroiditis, ILD-related definition

503

2758

1.91

37.41

1.3

1.1

7.02

2.07

u/ml

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

2963

15600

1.31

37.34

1.1

1.09

11.10

u/ml

2.50

190

Triptan medication for migraine, single purchase ok

2963

15600

1.31

37.34

1.1

1.09

11.10

u/ml

2.50

190

Cervicocranial syndrome

414

2125

2.03

37.34

1.1

1.03

3.24

u/ml

—

Immunodeficiency with predominantly antibody defects

163

562

3.26

37.33

1.4

1.1

72.29

1.04

u/ml

—

Other eating disorders

307

1425

2.32

37.21

1.2

54.08

4.52

u/ml

—

Renal tubulo-interstitial diseases

3108

17838

1.29

37.06

1.1

13.37

8.15

u/ml

0.25

208

Diabetic retinopathy, strict definition

643

3353

1.77

37.05

1.2

1.1

20.76

14.87

u/ml

—

Meniscus derangement

1680

7955

1.42

37.04

1.1

1.10

14.02

u/ml

1.71

Heart failure, not strict

2365

11984

1.35

37.02

1.1

23.63

8.98

u/ml

0.54

137

Eating disorders

536

3007

1.87

37.01

1.2

36.34

3.45

u/ml

—

Disorders of sclera, cornea, iris and ciliary body

1933

14290

1.38

36.80

1.1

13.79

11.43

u/ml

0.08

158

Other acute lower respiratory infections

1902

13346

1.38

36.61

1.1

3.71

11.30

u/ml

1.03

135

Other and unspecified nonorganic psychotic disorders

743

4558

1.68

36.59

1.1

1.25

8.72

u/ml

—

Neoplasms

2921

11849

1.31

36.45

1.1

18.80

10.21

u/ml

0.35

133

Fibroblastic disorders

687

4123

1.71

36.40

1.1

1.16

12.14

u/ml

—

Gonarthrosis [arthrosis of knee](FG)

2294

9887

1.35

36.38

1.1

1.72

11.15

u/ml

1.54

120

Acute sinusitis

1978

13336

1.37

36.34

1.1

14.42

8.29

u/ml

0.24

160

Disorders of psychological development

617

3352

1.78

36.33

1.2

2.58

15.57

u/ml

—

Immunodeficiencies

238

1005

2.56

36.01

1.4

1.2

72.29

2.09

u/ml

—

Bacterial pneumonia, not elsewhere classified

1285

7781

1.48

35.96

1.1

6.89

4.75

u/ml

—

Other heart diseases

1745

8200

1.41

35.78

1.1

24.84

8.89

u/ml

0.57

Coxarthrosis

1458

6587

1.45

35.56

1.1

0.93

13.97

u/ml

1.61

Other cataract

1386

7190

1.46

35.41

1.1

4.82

8.60

u/ml

0.28

Bacterial pneumoniae

1348

8260

1.46

35.37

1.1

25.54

4.65

u/ml

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

754

3178

1.68

35.07

1.1

23.75

3.60

u/ml

0.42

Lactose intolerance

174

640

2.98

35.04

1.2

1.1

—

1.00

—

Abrasion of teeth

1314

9202

1.46

34.84

1.1

13.13

7.49

u/ml

0.21

106

Other inflammation of eyelid, including avohilmo

1763

12973

1.38

34.77

1.1

1.84

11.49

u/ml

1.82

149

Other disorders of veins

1442

10099

1.43

34.67

1.1

11.55

7.87

u/ml

0.13

115

Atopic dermatitis, strict definition

1285

8777

1.47

34.64

1.2

1.1

1.10

12.92

u/ml

1.40

Bacterial pneumonia (organism specified)

1396

8918

1.44

34.59

1.1

25.54

4.09

u/ml

—

108

Other disorders of the musculoskeletal system and connective tissue

516

2914

1.83

34.52

1.2

1.1

0.99

1.83

u/ml

—

Senile cataract

1859

8290

1.38

34.31

1.1

1.55

7.57

u/ml

0.94

108

Spondylolisthesis/Spondylolysis

609

3609

1.74

34.14

1.1

7.78

7.35

u/ml

—

Suicide or other Intentional self-harm

906

5919

1.57

34.10

1.1

6.17

7.68

u/ml

—

Procreative management

1321

7624

1.46

33.97

1.1

1.91

11.67

u/ml

—

Trigger finger

514

2914

1.82

33.84

1.2

1.1

40.98

10.23

u/ml

—

Fissure and fistula of anal and rectal regions

759

4761

1.63

33.84

1.1

3.97

11.76

u/ml

0.56

Sequelae of injuries, of poisoning and of other consequences of external causes

815

5207

1.61

33.81

1.1

1.11

8.21

u/ml

—

Diseases of inner ear

1773

12526

1.38

33.74

1.1

1.55

5.85

u/ml

0.87

146

Other menopausal disorders

993

3621

1.57

33.61

1.1

0.88

2.29

u/ml

—

Artrosis, including avohilmo

2634

11130

1.31

33.50

1.1

1.08

11.63

u/ml

1.83

119

Keratitis

1255

8777

1.46

33.42

1.1

16.56

8.96

u/ml

0.24

Tinnitus

816

5233

1.60

33.35

1.1

1.15

6.24

u/ml

0.65

Benign neoplasm: Colon, unspecified

771

4876

1.62

33.33

1.1

6.84

6.06

u/ml

0.04

Symptoms and signs involving the urinary system

2515

14679

1.31

33.18

1.1

14.99

6.41

u/ml

0.35

168

Benign neoplasm of other and ill-defined parts of digestive system

612

3666

1.72

33.15

1.2

1.1

2.77

1.71

u/ml

—

Other obstetric conditions, not elsewhere classified

1410

6308

1.44

32.77

1.1

3.21

8.98

u/ml

0.66

L04AD Calcineurin inhibitors

439

2412

1.90

32.53

1.2

1.1

85.50

1.31

u/ml

—

Sequelae of external causes of morbidity and mortality

864

5648

1.57

32.36

1.1

2.16

10.69

u/ml

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

650

3985

1.69

32.31

1.2

1.1

7.28

10.61

u/ml

—

Viral and other specified intestinal infections

893

5742

1.56

32.26

1.2

1.1

1.12

7.41

u/ml

—

Other disorders of eyelid

1375

9261

1.42

32.16

1.1

21.78

3.81

u/ml

0.40

111

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1384

6185

1.44

32.05

1.1

3.31

9.08

u/ml

0.65

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2429

17204

1.30

31.94

1.2

1.1

2.81

11.89

u/ml

1.96

200

Acute bronchitis

1397

9832

1.42

31.91

1.1

2.60

10.31

u/ml

0.90

104

Polyarthrosis

668

3704

1.67

31.72

1.1

0.98

7.40

u/ml

0.62

Implicit bacterial Sepsis

1252

7546

1.45

31.46

1.1

2.21

4.54

u/ml

0.36

Paralytic ileus and intestinal obstruction

730

4609

1.61

31.45

1.1

1.03

12.29

u/ml

0.93

Other and unspecified effects of external causes

1062

7291

1.49

31.45

1.2

1.1

30.81

2.41

u/ml

0.44

Injuries to the wrist and hand

3710

20032

1.24

31.10

1.1

21.01

7.81

u/ml

0.53

259

Alcohol use disorder, Swedish definition

1654

11106

1.37

31.08

1.1

15.09

8.02

u/ml

0.20

124

Deviated nasal septum

960

6453

1.51

31.06

1.1

12.85

13.11

u/ml

—

Lactose intolerance, other/unspecified

152

558

2.98

30.79

1.2

1.1

—

1.03

—

Ulcer of lower limb, not elsewhere classified

442

2468

1.85

30.58

1.2

1.1

47.57

1.21

u/ml

—

Cutaneous abscess, furuncle and carbuncle

926

6221

1.52

30.50

1.2

1.1

30.48

11.03

u/ml

—

Bleeding

2691

14867

1.28

30.47

1.1

4.23

10.23

u/ml

0.74

162

Injuries to the head

4057

19789

1.23

30.39

1.1

7.48

9.40

u/ml

0.12

235

Other neurological diseases

2286

13720

1.31

30.32

1.1

2.50

7.59

u/ml

0.89

160

Atrial fibrillation and flutter with reimbursement

774

3101

1.61

30.18

1.1

45.56

3.43

u/ml

—

Schizophrenia or delusion

1085

7532

1.47

30.17

1.1

1.16

10.13

u/ml

1.16

Polycystic ovarian syndrome, consortium definition

2936

13398

1.28

30.13

1.1

13.32

3.51

u/ml

0.83

165

Impingement syndrome of shoulder

712

4530

1.61

30.01

1.2

1.1

0.92

11.80

u/ml

0.98

Inflammatory diseases of female pelvic organs

2554

13734

1.29

29.94

1.1

1.43

5.96

u/ml

1.38

176

Mouth breathing

1284

9182

1.42

29.94

1.2

1.1

1.99

15.15

u/ml

1.59

101

Noninflammatory disorders of female genital tract

1605

5880

1.40

29.89

1.2

1.1

4.27

10.81

u/ml

0.51

Other disorders of ear

3140

16297

1.26

29.81

1.1

1.85

10.62

u/ml

1.96

185

Hyperlipidaemia, other/unspecified

1072

6660

1.47

29.72

1.1

1.73

6.85

u/ml

—

Schizophrenia, schizotypal and delusional disorders

1086

7564

1.47

29.67

1.1

1.16

10.13

u/ml

1.16

Biological medication for rheuma

688

4369

1.62

29.60

1.1

22.04

18.57

u/ml

0.06

Acetic acid derivatives and related substances

838

2787

1.58

29.58

1.1

1.01

7.04

u/ml

—

Enthesopathies of lower limb, excluding foot

759

4920

1.58

29.51

1.1

30.57

6.68

u/ml

0.46

Bacterial Sepsis

1444

8692

1.39

29.43

1.1

2.04

5.42

u/ml

0.71

102

Atrial fibrillation and flutter

943

4068

1.52

29.40

1.1

28.41

4.45

u/ml

0.45

All pneumoniae

3684

19588

1.23

29.35

1.1

16.85

8.03

u/ml

0.39

245

Renal failure

1340

8229

1.41

29.10

1.1

33.69

5.43

u/ml

0.59

Injury, poisoning and certain other consequences of external causes

1953

7383

1.34

29.08

1.1

2.34

7.88

u/ml

0.96

Fracture of rib(s), sternum and thoracic spine

912

6164

1.51

28.99

1.1

2.02

10.57

u/ml

0.83

Disorders of vestibular function (Vertigo)

1528

11011

1.37

28.96

1.1

1.63

6.20

u/ml

0.81

130

Inflammatory bowel disease

1094

7668

1.46

28.92

1.1

20.03

5.27

u/ml

0.42

Certain disorders involving the immune mechanism

646

4063

1.64

28.87

1.2

1.1

63.38

2.19

u/ml

1.17

Plantar fascial fibromatosis

362

1940

1.94

28.84

1.1

1.33

2.65

u/ml

—

Allergic rhinitis

1266

8998

1.42

28.84

1.2

1.1

16.17

7.67

u/ml

0.23

Oter anti-inflammatory and antirheumatic agents, non-steroids

553

1779

1.74

28.62

1.1

1.16

8.38

u/ml

—

Urticaria and erythema

1392

10189

1.39

28.59

1.1

1.41

8.14

u/ml

0.96

109

Alcohol abuse, main dg, excluding more controls

466

2695

1.78

28.58

1.1

1.42

10.11

u/ml

—

Cerebrovascular diseases (FINNGEN)

986

4707

1.50

28.52

1.1

72.79

6.30

u/ml

—

Hallux valgus (acquired)

1071

5307

1.47

28.50

1.1

1.14

7.42

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

3650

19567

1.23

28.30

1.1

16.43

8.03

u/ml

0.38

245

Stomatitis and related lesions

742

4854

1.57

27.96

1.2

1.1

6.13

15.64

u/ml

0.48

Superficial injury of lower leg

981

6793

1.48

27.80

1.2

1.1

4.97

1.41

u/ml

0.83

Other bacterial diseases

3192

17155

1.24

27.70

1.1

19.08

7.87

u/ml

0.58

191

Benign neoplasm: Ascending colon

450

2608

1.78

27.61

1.1

2.21

1.69

u/ml

—

Lichen simplex chronicus and prurigo

242

1150

2.21

27.30

1.2

1.1

2.54

1.72

u/ml

—

Other bacterial intestinal infections

570

3522

1.66

27.26

1.1

1.26

1.94

u/ml

—

Maternal care for other conditions predominantly related to pregnancy

858

5675

1.51

27.14

1.1

3.32

6.08

u/ml

0.35

Congenital malformations, deformations and chromosomal abnormalities

2182

16218

1.29

27.10

1.2

1.1

2.64

10.63

u/ml

1.66

186

Adverse effects, not elsewhere classified

764

5078

1.55

26.81

1.2

1.1

37.37

2.88

u/ml

—

1862

12429

1.32

26.81

1.1

12.34

7.73

u/ml

0.16

139

Injuries to the elbow and forearm

2614

17937

1.26

26.81

1.1

5.54

9.64

u/ml

0.50

214

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3537

18382

1.23

26.79

1.1

16.56

8.14

u/ml

0.45

212

Rash and other nonspecific skin eruption

374

2078

1.88

26.76

1.2

1.1

0.93

1.24

u/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3545

19439

1.23

26.72

1.1

16.43

8.12

u/ml

0.38

242

Disorders of ocular muscles, binocular movement, accommodation and refraction

1814

13811

1.32

26.72

1.2

1.1

27.64

8.14

u/ml

0.55

161

Coxarthrosis [arthrosis of hip](FG)

1581

8132

1.35

26.45

1.1

0.93

11.70

u/ml

1.62

107

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1485

6922

1.37

26.40

1.1

13.26

5.27

u/ml

0.30

Enlarged lymph nodes

536

3291

1.67

26.36

1.1

5.97

14.57

u/ml

—

Speech and linguistic disorders

456

2588

1.77

26.29

1.2

3.36

18.31

u/ml

—

GI-bleeding

886

6069

1.48

26.25

1.2

1.1

1.52

1.00

u/ml

0.86

Striking against or struck by other objects

1194

8629

1.41

26.25

1.1

4.68

9.64

u/ml

—

Chronic periodontitis, complicated

1760

13138

1.32

26.23

1.1

2.55

7.94

u/ml

1.01

163

Psoriasis

928

6430

1.47

26.17

1.1

20.22

10.23

u/ml

0.31

Substance abuse

1825

13040

1.32

26.13

1.1

19.88

7.08

u/ml

0.43

152

1756

12011

1.32

25.77

1.1

13.34

7.90

u/ml

0.18

134

Emotional disorders and disorders of social functioning with onset specific to childhood

312

1640

1.99

25.47

1.3

1.2

60.83

4.11

u/ml

—

Recurrent aphthous stomatitis , including avohilmo

551

3446

1.65

25.43

1.2

1.1

6.06

2.45

u/ml

—

Erysipelas, including avohilmo

2325

13657

1.27

25.33

1.1

13.07

6.76

u/ml

0.28

153

Memory loss

289

1503

2.00

25.29

1.1

—

0.88

—

Urticaria

1151

8344

1.41

25.25

1.1

1.55

9.97

u/ml

0.91

Superficial injury of wrist and hand

815

5555

1.50

25.24

1.1

4.43

7.33

u/ml

—

Gout

664

3690

1.57

25.16

1.1

1.17

15.70

u/ml

—

Injuries to the neck

819

5589

1.50

25.11

1.2

1.1

36.32

2.07

u/ml

—

Disorders of breast

1904

13042

1.31

25.11

1.1

5.32

5.13

u/ml

0.01

151

Acute tubulo-interstitial nephritis

2163

14411

1.28

25.02

1.1

12.39

6.98

u/ml

0.20

163

Mental and behavioural disorders due to psychoactive substance use

1876

13347

1.30

24.89

1.1

19.02

8.33

u/ml

0.36

153

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

262

4811

0.52

24.78

1.1

0.97

6.04

u/ml

—

Rheumatoid arthritis, including avohilmo

1218

8933

1.39

24.72

1.1

14.17

7.13

u/ml

0.21

105

Ischaemic heart disease, wide definition

2274

11065

1.28

24.69

1.1

12.14

7.55

u/ml

0.18

129

Ulcerative colitis

820

5614

1.49

24.68

1.1

20.47

1.85

u/ml

0.50

Other diseases of the digestive system

884

6128

1.47

24.67

1.2

1.1

1.52

1.00

u/ml

0.85

Diseases of male genital organs

1255

4562

1.40

24.66

1.1

34.15

14.08

u/ml

—

Other and unspecified disorders of vitreous body

1343

9776

1.37

24.63

1.1

1.71

3.95

u/ml

0.49

110

Ganglion

703

4671

1.54

24.51

1.1

0.86

11.41

u/ml

0.98

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1485

11089

1.34

24.51

1.1

4.13

9.40

u/ml

0.72

139

Sequelae with surgical and medical care as external cause

659

4324

1.56

24.48

1.1

2.45

1.58

u/ml

—

Diabetes mellitus in pregnancy

1313

6150

1.38

24.34

1.2

1.1

2.14

5.94

u/ml

0.68

Fracture of lower leg, including ankle

1859

14226

1.30

24.31

1.1

3.23

8.13

u/ml

0.80

161

Sulfasalazine

941

6628

1.45

24.28

1.1

0.90

5.33

u/ml

0.69

Hyperplasia of prostate

759

2824

1.53

24.26

1.1

1.79

17.76

u/ml

—

Hypokalaemia

401

2335

1.77

24.23

1.1

0.93

1.55

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3093

16025

1.23

24.22

1.1

11.92

7.75

u/ml

0.23

179

Tonsillectomy and adenotomy

2192

12079

1.28

24.21

1.2

1.1

3.68

10.14

u/ml

0.90

154

Abnormal findings on diagnostic imaging of other body structures

504

3121

1.66

24.18

1.1

1.50

1.84

u/ml

—

Acute renal failure

618

4003

1.58

24.16

1.1

55.26

6.66

u/ml

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

554

3511

1.63

24.10

1.1

64.84

1.97

u/ml

—

Other hammer toe(s) (acquired)

533

3030

1.64

24.06

1.1

1.00

1.63

u/ml

—

Erysipelas

1677

11110

1.32

23.95

1.1

14.75

7.84

u/ml

0.21

122

Other specified/unspecified systemic involvement of connective tissue

239

1192

2.12

23.94

1.1

1.73

0.86

u/ml

—

Infections with a predominantly sexual mode of transmission, including avohilmo

1550

10818

1.33

23.87

1.1

10.87

8.16

u/ml

0.10

124

Lichen ruber planus, wide definition including periferal and oral lichen planus

755

5130

1.51

23.76

1.1

1.23

7.07

u/ml

—

Other hearing loss

805

5346

1.48

23.75

1.1

0.93

5.46

u/ml

—

Obesity due to excess calories

1705

13204

1.31

23.74

1.1

1.03

10.92

u/ml

2.20

155

Conjunctivitis (acute, non atopic)

1056

7593

1.41

23.70

1.1

18.05

9.37

u/ml

0.21

Diabetic retinopathy, excluding more controls

919

3569

1.48

23.62

1.2

1.1

13.44

7.62

u/ml

—

Type 2 diabetes, strict (exclude DM1)

3036

14477

1.23

23.54

1.1

8.83

6.37

u/ml

0.12

177

Tumor necrosis factor alpha inhibitors

607

3953

1.58

23.53

1.1

23.97

19.50

u/ml

0.08

Type 2 diabetes, definitions combined

3024

14417

1.23

23.48

1.1

8.83

6.37

u/ml

0.12

177

Anorexia (incl.atypical)

278

1470

1.99

23.47

1.2

46.39

4.49

u/ml

—

Seropositive rheumatoid arthritis

775

5271

1.49

23.40

1.1

23.04

5.92

u/ml

—

Benign neoplasm: Rectum

541

3431

1.62

23.39

1.1

1.34

1.66

u/ml

—

Other noninflammatory disorders of vulva and perineum

387

2260

1.78

23.36

1.1

5.60

2.24

u/ml

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

605

3942

1.58

23.27

1.1

54.25

10.61

u/ml

—

Hard cardiovascular diseases

2662

12740

1.25

23.25

1.1

25.91

7.71

u/ml

0.66

144

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1273

9393

1.36

23.24

1.1

22.64

9.31

u/ml

0.26

103

Benign neoplasm: Stomach

327

1821

1.87

23.24

1.2

1.1

0.82

1.33

u/ml

—

Benign neoplasm: Rectum, anus and anal canal

593

3846

1.58

23.20

1.1

1.27

7.04

u/ml

0.52

Female genital prolapse

967

3776

1.45

23.12

1.1

1.74

2.21

u/ml

—

Lateral epicondylitis

429

2585

1.71

22.83

1.1

0.77

11.71

u/ml

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1049

7612

1.40

22.80

1.1

1.05

5.23

u/ml

0.78

Dermatophytosis, including avohilmo

2208

17354

1.26

22.71

1.1

8.28

7.54

u/ml

0.05

211

Diplopia

430

2601

1.70

22.63

1.1

6.03

1.18

u/ml

—

Injuries to the shoulder and upper arm

2873

18238

1.23

22.43

1.1

11.43

8.18

u/ml

0.12

216

Complications of internal orthopaedic prosthetic devices, implants and grafts

669

4484

1.52

22.42

1.2

1.1

1.15

6.45

u/ml

—

Chronic kidney disease

840

5645

1.45

22.41

1.1

17.26

5.13

u/ml

—

Zoster [herpes zoster], including avohilmo

1663

12466

1.30

22.39

1.1

1.88

4.13

u/ml

0.46

147

All chronic kidney diseases

1685

10414

1.31

22.38

1.1

23.91

7.49

u/ml

0.46

115

Selective deficiency of immunoglobulin A [IgA]y

113

5.88

22.36

2.0

1.1

72.29

—

u/ml

—

Uterine polyps

962

3977

1.44

22.36

1.1

1.85

2.15

u/ml

0.11

Lesion of ulnar nerve

435

2646

1.69

22.33

1.1

17.45

2.15

u/ml

0.43

Superficial injury of ankle and foot

504

3187

1.63

22.31

1.2

1.1

7.06

11.07

u/ml

—

Female infertility, cervical, vaginal, other or unspecified origin

999

4572

1.43

22.19

1.1

2.04

7.74

u/ml

0.51

Other symptoms and signs involving the digestive system and abdomen

571

3714

1.57

22.11

1.2

1.1

1.00

1.83

u/ml

—

Neuralgia and neuritis, unspecified

191

901

2.22

22.03

1.1

—

0.84

—

Injuries to the hip and thigh

1484

10187

1.32

22.01

1.1

3.95

7.31

u/ml

0.38

114

Brachial plexus disorders

346

1993

1.80

21.95

1.2

1.1

2.10

2.49

u/ml

—

Triptan medication for migraine, min. 3 purchases

2201

13208

1.26

21.88

1.1

1.14

8.41

u/ml

1.75

164

Postmenopausal atrophic vaginitis

853

3223

1.47

21.85

1.1

1.01

2.27

u/ml

—

Exclusions for E4_PCOS_BROAD

642

4298

1.53

21.80

1.2

1.06

18.22

u/ml

—

Sacrococcygeal disorders, not elsewhere classified

136

560

2.59

21.77

1.1

—

0.84

—

Type 2 diabetes, definitions combined, including avohilmo

3030

14469

1.22

21.76

1.1

8.61

6.34

u/ml

0.12

178

Other symptoms and signs involving the nervous and musculoskeletal systems

1399

10678

1.33

21.71

1.2

1.1

2.67

6.85

u/ml

0.60

118

Thyrotoxicosis, other and/or unspecified

707

4830

1.50

21.70

1.2

1.1

1.56

1.62

u/ml

—

Mental and behavioural disorders due to alcohol

1513

11094

1.31

21.69

1.1

16.71

8.00

u/ml

0.23

124

Oxicams

608

2232

1.57

21.63

1.1

0.80

8.20

u/ml

1.18

Transient ischemic attack

1470

8957

1.32

21.59

1.1

3.59

1.80

u/ml

0.34

110

Intracranial injury

1967

14596

1.27

21.46

1.1

2.03

9.97

u/ml

1.56

161

All influenza

849

6006

1.44

21.41

1.1

43.68

6.80

u/ml

0.66

Other disorders of bladder

336

1927

1.79

21.41

1.1

1.73

0.94

u/ml

—

Benign paroxysmal vertigo

936

6742

1.41

21.36

1.1

2.00

1.69

u/ml

0.11

Other viral diseases, not elsewhere classified, including avohilmo

1016

7389

1.39

21.10

1.2

1.1

3.38

7.02

u/ml

0.31

Cluster headache, strict

153

674

2.41

21.02

1.1

—

0.84

—

Vitamin B12 deficiency anaemia

296

1646

1.85

20.95

1.1

2.56

1.29

u/ml

—

Other viral diseases, including avohilmo

1429

10899

1.32

20.82

1.2

1.1

18.89

7.89

u/ml

0.29

118

Superficial injury of head

807

5691

1.44

20.66

1.1

1.06

7.56

u/ml

—

Menorrhagia

1179

4871

1.37

20.62

1.2

1.1

7.89

7.25

u/ml

0.03

Percutaneous Coronary Intervention

2425

11993

1.24

20.58

1.1

18.54

8.07

u/ml

0.40

136

Other CVD

538

3506

1.56

20.53

1.1

1.88

1.15

u/ml

—

Mycoses

916

6623

1.41

20.46

1.1

2.40

9.47

u/ml

0.68

Cluster headache, wide

159

720

2.33

20.44

1.1

—

0.84

—

1123

7520

1.36

20.35

1.1

21.64

4.84

u/ml

0.45

Gonarthrosis,primary

2624

12989

1.23

20.24

1.1

1.74

8.27

u/ml

1.37

160

Fracture at wrist and hand level

1156

8649

1.35

20.23

1.2

1.1

64.74

11.13

u/ml

—

105

Disorders of continuity of bone

369

2215

1.72

20.19

1.2

1.1

2.50

2.29

u/ml

—

Coronary revascularization (ANGIO or CABG)

2424

12001

1.24

20.14

1.1

18.00

8.07

u/ml

0.39

136

Emergency coronary revascularization (for ACS)

2573

12737

1.23

20.11

1.1

17.51

9.36

u/ml

0.31

144

Bacterial intestinal infections, IBD co-morbidities

558

3687

1.55

20.11

1.1

1.15

1.68

u/ml

—

Thyrotoxicosis

865

6219

1.42

20.08

1.2

1.1

1.49

1.82

u/ml

0.19

Coagulation defects, purpura and other haemorrhagic conditions

639

4346

1.50

20.07

1.2

1.1

1.82

2.54

u/ml

—

Fall on and from stairs and steps

863

6201

1.42

20.03

1.1

2.05

6.51

u/ml

—

Heart failure and antihypertensive medication

668

2931

1.51

20.03

1.1

62.19

3.31

u/ml

—

Coronary atherosclerosis

1823

9090

1.28

20.01

1.1

13.14

6.32

u/ml

0.23

Benign neoplasm: Transverse colon

331

1933

1.77

19.96

1.1

2.29

1.26

u/ml

—

Alcohol use disorder, ICD-based

1164

8770

1.35

19.76

1.1

24.36

9.10

u/ml

0.27

Biguanides

3104

15673

1.21

19.74

1.1

16.33

6.02

u/ml

0.47

192

Misadventures to patients during surgical and medical care

465

2968

1.61

19.71

1.1

1.14

1.79

u/ml

—

Adalimumab

377

2292

1.70

19.69

1.1

29.57

1.43

u/ml

—

Internal derangement of knee

1112

8250

1.35

19.54

1.1

3.14

14.16

u/ml

1.31

Infections with a predominantly sexual mode of transmission

1125

8446

1.35

19.51

1.2

1.1

18.95

9.50

u/ml

0.21

Ischemic heart diseases

2552

12495

1.23

19.37

1.1

25.36

7.95

u/ml

0.68

139

Angina pectoris

1571

8134

1.30

19.35

1.1

18.58

6.07

u/ml

0.36

Dislocation, sprain and strain of joints and ligaments at neck level

563

3772

1.53

19.19

1.2

1.1

44.74

1.82

u/ml

—

Psoriasis vulgaris

578

3894

1.52

19.06

1.1

37.02

10.07

u/ml

—

Actinic keratosis

1009

6796

1.37

19.02

1.1

25.46

5.03

u/ml

0.47

Substance use, excluding alcohol

655

4527

1.48

18.95

1.1

13.76

8.42

u/ml

—

Pneumonia, organism unspecified

3132

18081

1.20

18.91

1.1

17.26

7.48

u/ml

0.44

220

Other or unspecified ileus, impaction or obstruction

473

3051

1.58

18.88

1.1

1.05

8.34

u/ml

0.54

Early onset COPD, excluding more controls

529

3495

1.54

18.88

1.1

56.18

7.45

u/ml

—

Skin changes due to chronic exposure to nonionizing radiation

1043

7036

1.36

18.85

1.1

24.01

4.91

u/ml

0.46

Viral infections characterized by skin and mucous membrane lesions

1411

10989

1.30

18.78

1.1

20.61

9.58

u/ml

0.26

123

Seronegative rheumatoid arthritis

372

2279

1.68

18.73

1.1

0.88

2.14

u/ml

—

Exclusions for E4_PCOS_CONSORTIUM

2755

14322

1.21

18.69

1.1

9.17

8.12

u/ml

0.04

169

Primary biliary cholangitis (PBC)

367

2.85

18.62

1.1

—

5-aminosalicylic acid

695

4890

1.45

18.24

1.1

28.27

1.59

u/ml

0.46

Bacterial infection, other or unspecified, including avohilmo

1795

11795

1.26

18.19

1.1

13.53

9.61

u/ml

0.14

124

Other problems related to primary support group, including family circumstances

504

3253

1.56

18.19

1.2

14.76

14.26

u/ml

—

Other and unspecified visual disturbances

372

2302

1.67

18.11

1.2

1.1

56.68

1.18

u/ml

—

Other disorders of bone

650

4529

1.47

18.07

1.1

1.25

14.82

u/ml

—

Disorder of lipoprotein metabolism, unspecified

343

2075

1.69

18.02

1.1

42.45

0.97

u/ml

—

Polyp of the female genital tract

989

4131

1.38

17.92

1.1

1.95

2.15

u/ml

0.06

Abnormal findings on diagnostic imaging of lung

1339

9863

1.30

17.91

1.1

12.69

7.28

u/ml

0.26

111

Lichen planus, including avohilmo

614

4242

1.48

17.90

1.1

1.30

8.47

u/ml

—

Propionic acid derivatives

907

3308

1.40

17.67

1.1

2.09

14.03

u/ml

—

Paroxysmal tachycardia

727

4286

1.43

17.67

1.1

31.31

3.14

u/ml

0.59

Nonsuppurative otitis media, including avohilmo

1239

8270

1.32

17.58

1.2

1.1

12.29

9.08

u/ml

0.17

Glomerular diseases

529

3560

1.52

17.57

1.2

1.1

15.03

9.94

u/ml

—

Hypo-osmolality and hyponatraemia

482

3152

1.55

17.55

1.1

0.85

1.66

u/ml

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1018

7669

1.35

17.54

1.1

20.93

8.94

u/ml

—

Periapical abscess

1481

11723

1.28

17.43

1.1

22.38

9.48

u/ml

0.35

129

Medical abortion

2376

10617

1.23

17.42

1.1

1.48

3.64

u/ml

1.01

127

Fracture of femur

712

4553

1.43

17.41

1.1

3.18

1.53

u/ml

—

Pollen allergy

784

5614

1.41

17.32

1.2

21.61

8.91

u/ml

0.25

Glucagon-like peptide-1 (GLP-1) analogues

942

7029

1.36

17.29

1.1

1.07

7.39

u/ml

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

942

7029

1.36

17.29

1.1

1.07

7.39

u/ml

—

Other maternal disorders predominantly related to pregnancy

2133

10939

1.24

17.23

1.2

1.1

2.81

5.06

u/ml

0.54

129

Persons encountering health services in circumstances related to reproduction

1994

10894

1.24

17.08

1.1

5.40

12.61

u/ml

0.81

133

Dysplasia of cervi uteri

849

4362

1.39

17.06

1.1

29.48

7.27

u/ml

0.52

Unspecified lump in breast

567

3902

1.49

17.04

1.1

17.53

1.65

u/ml

—

Atrophic disorders of skin

558

3829

1.49

16.96

1.2

1.1

1.18

2.07

u/ml

—

Other disorders of patella

544

3714

1.50

16.83

1.1

1.89

11.02

u/ml

—

Thyrotoxicosis with diffuse goitre

498

3347

1.53

16.81

1.2

1.1

1.88

1.82

u/ml

—

Covid-19 suspected case

753

5455

1.41

16.81

1.1

20.53

2.13

u/ml

0.61

Psoriatic and enteropathic arthropathies

364

2281

1.64

16.76

1.1

5.51

2.74

u/ml

—

Psoriatic arthropathies

306

1838

1.71

16.67

1.1

1.27

17.21

u/ml

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

448

2960

1.56

16.51

1.1

1.00

3.13

u/ml

—

Major coronary heart disease event

2529

12638

1.21

16.41

1.1

24.63

7.84

u/ml

0.67

141

Female infertility

1040

4709

1.35

16.38

1.1

2.23

7.39

u/ml

0.48

Postmenopausal bleeding

819

3107

1.40

16.36

1.1

2.20

1.71

u/ml

—

Blepharochalasis

849

6309

1.37

16.07

1.1

1.18

4.79

u/ml

—

Emotional disorders starting during childhood or adolescence

282

1676

1.76

16.04

1.3

1.2

9.00

27.54

u/ml

—

Benign neoplasm: Caecum

316

1939

1.68

15.93

1.1

0.99

1.26

u/ml

—

Anti-inflammatory and antirheumatic products, non-steroids

894

3312

1.37

15.88

1.1

2.22

14.03

u/ml

—

Other and unspecified urticaria

698

5057

1.41

15.68

1.2

1.1

1.87

8.64

u/ml

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1514

9503

1.26

15.61

1.1

36.91

5.50

u/ml

0.68

114

Diseases of external ear

1120

8693

1.31

15.55

1.1

55.25

11.10

u/ml

0.84

103

Gout, idiopatic and unspecified

591

4162

1.44

15.41

1.1

1.22

12.06

u/ml

—

Candidiasis

488

3329

1.50

15.33

1.1

2.46

2.06

u/ml

—

Mucosal proctocolitis

410

2697

1.56

15.33

1.1

1.15

1.14

u/ml

—

Disorders of mineral metabolism

268

1592

1.73

15.32

1.1

1.18

0.88

u/ml

—

Colectomy operation

466

3150

1.51

15.22

1.1

11.90

1.69

u/ml

—

Fracture of shoulder and upper arm

1136

8848

1.30

15.16

1.1

1.61

5.30

u/ml

—

Gout, FINNGEN

664

4752

1.41

15.11

1.1

1.17

10.83

u/ml

—

Pregnancy examination and test

639

2813

1.44

15.10

1.2

1.1

2.43

2.29

u/ml

—

Herpesviral [herpes simplex] infections, including avohilmo

915

6948

1.34

15.07

1.1

0.83

6.15

u/ml

—

Diabetic maculopathy

410

2562

1.56

14.94

1.2

20.52

10.67

u/ml

—

Benign neoplasm: Sigmoid colon

524

3638

1.47

14.91

1.1

0.98

1.72

u/ml

0.81

Unspecified haematuria

1096

6912

1.30

14.90

1.1

30.10

10.09

u/ml

0.41

Disorders of parathyroid gland

601

4226

1.43

14.89

1.1

1.06

1.88

u/ml

—

Use of pramipexole

636

4575

1.42

14.84

1.1

1.22

1.72

u/ml

—

Diabetic retinopathy

1051

5013

1.32

14.79

1.2

1.1

12.02

11.21

u/ml

—

Intestinal stricture

847

6376

1.35

14.68

1.1

1.05

9.68

u/ml

0.93

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

249

1471

1.75

14.68

1.2

1.1

—

1.91

—

Glucosamine medication

1289

8160

1.28

14.55

1.1

1.36

4.17

u/ml

0.50

Fracture of forearm

1910

14215

1.22

14.54

1.1

5.62

7.77

u/ml

0.19

167

ILD medications: azathioprine

489

3373

1.48

14.50

1.2

1.1

11.92

1.99

u/ml

0.60

Disorders of refraction and accommodation

1030

7968

1.31

14.37

1.2

1.1

27.24

6.09

u/ml

0.35

Azathioprine

489

3384

1.48

14.26

1.2

1.1

11.92

1.76

u/ml

0.62

Other (seronegative) rheumatoid arthritis, wide

562

3995

1.43

14.11

1.1

20.72

1.64

u/ml

—

Alcohol abuse, main dg

466

3205

1.48

14.00

1.1

1.42

9.87

u/ml

—

Bacterial infection, other or unspecified

1562

10730

1.24

13.97

1.1

16.37

7.51

u/ml

0.29

115

Other diseases of arteries and capillaries

270

1651

1.68

13.85

1.1

66.24

0.99

u/ml

—

Acute pharyngitis

569

4031

1.43

13.79

1.2

1.1

5.51

2.29

u/ml

—

Inflammatory diseases of prostate (prostatitis)

274

1683

1.66

13.64

1.1

0.98

14.12

u/ml

—

Ovarian dysfunction

334

2167

1.60

13.60

1.2

1.1

0.76

2.26

u/ml

—

Otitis externa

741

5545

1.36

13.55

1.1

41.21

8.03

u/ml

—

Endometriosis of pelvic peritoneum

553

3592

1.43

13.38

1.1

2.84

2.50

u/ml

—

Diseases of arteries, arterioles and capillaries

1800

10929

1.22

13.37

1.1

35.19

4.57

u/ml

0.69

129

Allergic contact dermatitis

455

3148

1.48

13.36

1.1

1.73

2.52

u/ml

—

Childhood asthma (age<16)

538

2978

1.44

13.36

1.2

1.1

1.16

2.53

u/ml

—

Cramp and spasm

174

956

1.90

13.27

1.1

—

0.89

—

Fracture of skull and facial bones

644

4732

1.38

13.22

1.1

1.08

14.62

u/ml

—

Childhood asthma (age<16), excluding more controls

537

2979

1.44

13.16

1.2

1.1

1.16

2.53

u/ml

—

Diseases of middle ear and mastoid

2013

13802

1.20

13.16

1.2

1.1

7.35

9.40

u/ml

0.18

160

Reactive arthropathies

258

1582

1.67

13.11

1.1

40.72

21.45

u/ml

—

Seropositive rheumatoid arthritis, wide

774

5858

1.34

13.08

1.1

23.04

1.68

u/ml

—

Other abnormal products of conception

1202

6277

1.27

13.03

1.1

12.73

4.71

u/ml

0.30

Superficial injury of hip and thigh

434

2984

1.48

13.03

1.1

1.00

1.13

u/ml

—

Melanocytic naevi

1025

8058

1.29

13.01

1.2

1.1

23.66

1.93

u/ml

0.52

Other strabismus

766

5776

1.34

13.00

1.2

24.35

8.21

u/ml

0.33

IBD patients in KELA-register

719

5392

1.35

12.96

1.1

5.96

1.90

u/ml

0.62

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

759

5740

1.34

12.92

1.1

23.04

1.72

u/ml

—

Other skin changes

576

4178

1.40

12.86

1.1

0.94

1.83

u/ml

—

Hernia of abdominal wall

1279

10324

1.25

12.82

1.1

1.68

9.61

u/ml

1.30

125

Parkinson's disease, strict definition, excluding more controls

293

1729

1.61

12.81

1.1

2.36

1.57

u/ml

—

Other/unspecified seropositive rheumatoid arthritis

765

5800

1.34

12.79

1.1

23.04

1.69

u/ml

—

Corneal ulcer

572

4151

1.40

12.76

1.1

1.19

9.96

u/ml

0.59

Posteruptive colour changes of dental hard tissues

5.46

12.42

1.1

—

Acne, including avohilmo

932

5881

1.30

12.41

1.1

56.27

9.72

u/ml

—

Other noninflammatory disorders of uterus, except cervix

645

3170

1.38

12.36

1.1

12.22

1.71

u/ml

0.47

Other degenerative diseases of the nervous system

748

4110

1.34

12.35

1.1

0.99

3.51

u/ml

—

Ulcerative colitis, NAS

428

2981

1.47

12.14

1.1

44.84

1.86

u/ml

—

Otalgia

316

2077

1.57

12.12

1.2

2.04

15.19

u/ml

—

Malignant neoplasm of respiratory system and intrathoracic organs

244

3215

0.62

12.02

1.1

3.37

8.88

u/ml

—

Open wound of head

1615

12615

1.21

11.91

1.1

18.76

9.13

u/ml

0.26

140

Gout, unspecified

469

3331

1.43

11.82

1.1

1.22

14.12

u/ml

—

Colonic or urogenital fistula

776

5968

1.32

11.72

1.1

3.79

10.43

u/ml

0.54

Benign thyroid growths and nodules

999

7362

1.28

11.70

1.1

1.87

1.43

u/ml

0.23

Other benign neoplasms of skin

1086

8704

1.26

11.70

1.1

5.79

7.58

u/ml

0.11

103

Liquid cancers

805

5881

1.31

11.67

1.1

17.61

11.06

u/ml

0.14

Methotrexate

430

3023

1.45

11.62

1.1

26.01

1.93

u/ml

—

Primary gonarthrosis, bilateral

1414

9735

1.23

11.60

1.1

2.01

6.42

u/ml

0.75

127

Endometriosis of ovary

548

3776

1.39

11.60

1.2

1.1

1.98

2.29

u/ml

—

Other disorders of breast

492

3549

1.42

11.58

1.1

1.98

2.17

u/ml

—

Syphilis, including avohilmo

398

2.32

11.55

1.2

1.1

—

0.80

—

Syphilis

398

2.32

11.55

1.2

1.1

—

0.80

—

Strabismus

880

6884

1.29

11.47

1.2

1.1

24.35

7.46

u/ml

0.35

Ventral hernia

653

4917

1.35

11.47

1.1

1.04

11.20

u/ml

—

Acute appendicitis

2207

17556

1.18

11.44

1.1

8.63

8.27

u/ml

0.02

210

Umbilical hernia

720

5500

1.33

11.40

1.1

2.08

17.31

u/ml

—

Idiopathic urticaria

101

488

2.20

11.39

1.1

—

1.00

—

Parkinson's disease, excluding more controls

308

1863

1.54

11.39

1.1

2.36

1.56

u/ml

—

Panniculitis affecting regions of neck and back

115

579

2.06

11.37

1.2

1.1

—

0.83

—

Seborrhoeic keratosis

703

5358

1.33

11.36

1.1

52.76

1.76

u/ml

0.75

Hyperparathyroidism

501

3590

1.40

11.30

1.1

1.06

1.65

u/ml

—

Disorders of calcium metabolism

194

1153

1.73

11.24

1.1

1.18

0.91

u/ml

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

298

3674

0.66

11.20

1.1

3.37

7.00

u/ml

—

Hallux rigidus

377

2605

1.47

11.16

1.1

1.23

9.84

u/ml

—

Vitamin deficiency, wide

165

941

1.82

11.15

1.2

1.1

5.85

0.94

u/ml

—

Vitamin deficiency

165

941

1.82

11.15

1.2

1.1

5.85

0.94

u/ml

—

Arthropathic psoriasis

335

2266

1.51

11.13

1.1

1.23

1.43

u/ml

—

False labour

1121

5595

1.26

11.10

1.1

18.47

9.13

u/ml

0.23

In situ neoplasms

1195

9738

1.24

11.09

1.1

28.11

3.86

u/ml

0.41

111

Unstable angina pectoris

870

5346

1.29

11.07

1.1

28.16

3.31

u/ml

—

Appendicitis, broad definition

2345

18167

1.17

11.02

1.1

8.26

8.28

u/ml

0.00

219

Benign neoplasm of mouth and pharynx

313

2096

1.53

10.94

1.1

1.05

1.23

u/ml

—

Viral warts, including avohilmo

751

5813

1.31

10.93

1.1

35.09

7.07

u/ml

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

440

3144

1.43

10.88

1.1

0.98

12.25

u/ml

—

Acute appendicitis, no complications

1753

14753

1.19

10.76

1.1

10.99

9.83

u/ml

0.04

169

Diseases of appendix

2359

18254

1.16

10.74

1.1

8.26

8.24

u/ml

0.00

220

Inflammatory bowel disease, strict (require KELA)

719

5549

1.31

10.67

1.1

5.96

7.46

u/ml

0.09

Explicit Sepsis, including avohilmo

1292

9639

1.23

10.66

1.1

12.61

4.79

u/ml

0.31

109

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1835

11464

1.19

10.63

1.1

19.04

4.46

u/ml

0.58

149

Haemorrhage in early pregnancy

964

7499

1.27

10.58

1.1

2.09

5.02

u/ml

0.60

Lyme disease, including avohilmo

1022

8238

1.26

10.57

1.1

0.78

7.80

u/ml

—

Lyme disease

1022

8238

1.26

10.57

1.1

0.78

7.80

u/ml

—

Other symptoms and signs involving the circulatory and respiratory systems

201

1226

1.68

10.54

1.2

1.1

—

1.44

—

Epilepsy

892

7053

1.27

10.54

1.1

1.12

10.55

u/ml

1.01

Other and unspecified injuries of ankle and foot

166

967

1.78

10.50

1.2

1.1

—

1.91

—

Other and unspecified tonsillitis

1161

7871

1.24

10.45

1.2

1.1

2.54

12.77

u/ml

1.27

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

546

4070

1.36

10.40

1.1

1.19

10.75

u/ml

—

Other spirochaetal diseases

1031

8336

1.25

10.38

1.1

16.98

7.80

u/ml

—

Glaucoma

1534

10919

1.20

10.36

1.1

1.03

6.50

u/ml

1.04

126

Spirochaetal infections, other/unspecified, including avohilmo

1028

8314

1.25

10.33

1.1

0.78

7.74

u/ml

—

100

Nonsuppurative otitis media

880

6065

1.28

10.23

1.2

1.1

15.83

7.27

u/ml

—

Malignant neoplasm of bronchus and lung

211

2783

0.63

10.17

1.1

3.70

9.72

u/ml

—

Causalgia

293

2.48

10.15

1.1

—

Other spirochaetal diseases, including avohilmo

1041

8456

1.25

10.06

1.1

16.98

7.73

u/ml

—

100

Golimumab

135

751

1.88

10.04

1.1

—

1.00

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

493

3639

1.38

10.04

1.1

1.19

11.64

u/ml

—

Otitis media, unspecified

458

3078

1.40

10.04

1.2

3.83

3.36

u/ml

—

Ulcerative colitis (strict definition, require KELA)

507

3760

1.37

10.01

1.1

1.19

11.64

u/ml

—

Conductive and sensorineural hearing loss

2273

13063

1.16

9.95

1.1

4.07

7.62

u/ml

0.44

154

Progressive vascular leukoencephalopathy

108

559

2.00

9.90

1.1

—

2.15

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

860

6857

1.27

9.80

1.1

1.11

6.15

u/ml

0.80

ILD, hospital admissions 1, main diag only

335

2324

1.47

9.78

1.1

0.88

1.21

u/ml

—

Postprocedural disorders of nervous system

252

1656

1.57

9.78

1.2

1.1

1.14

2.06

u/ml

—

Contraceptive management

1309

7593

1.22

9.71

1.1

2.86

7.50

u/ml

0.58

Malignant neoplasm of bronchus and lung, including Hilmo

258

3217

0.66

9.67

1.1

3.70

8.44

u/ml

—

Fitting and adjustment of other devices

595

6834

0.76

9.65

1.1

1.17

4.78

u/ml

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

690

5380

1.30

9.62

1.1

1.11

5.70

u/ml

—

Other symptoms and signs involving the urinary system

277

1861

1.52

9.55

1.1

1.26

1.35

u/ml

—

Coxarthrosis, primary

1590

11180

1.19

9.54

1.1

0.91

6.90

u/ml

1.25

132

Viral warts

335

2343

1.46

9.49

1.2

1.1

35.74

2.18

u/ml

—

Other specified/unspecified bacterial intestinal infections

202

1270

1.64

9.49

1.1

—

1.46

—

Pregnancy with abortive outcome

2372

10757

1.16

9.44

1.1

2.04

3.60

u/ml

0.62

129

Explicit Sepsis

1244

9418

1.21

9.34

1.1

14.02

4.62

u/ml

0.33

106

Benign neoplasm: Skin of eyelid, including canthus

432

3165

1.39

9.27

1.2

1.1

0.97

1.77

u/ml

—

Suppurative and unspecified otitis media

1277

9439

1.21

9.26

1.2

1.1

7.53

11.14

u/ml

0.26

104

Gastroduodenal ulcer

574

4367

1.32

9.20

1.1

25.29

8.69

u/ml

—

Primary_lymphoid and hematopoietic malignant neoplasms

612

4721

1.31

9.15

1.1

19.15

6.71

u/ml

0.29

Cardiodefibrillation

803

6385

1.27

9.12

1.1

41.69

5.34

u/ml

—

Short stature, not elsewhere classified

168

963

1.76

9.07

1.3

1.2

—

64.80

—

Glaucoma suspect

993

8111

1.24

9.06

1.1

0.99

7.93

u/ml

0.90

Other viral diseases

979

7967

1.24

9.05

1.2

1.1

23.24

6.32

u/ml

0.37

Unspecified acute lower respiratory infection

425

3119

1.38

9.00

1.2

1.1

6.89

1.14

u/ml

—

Crohn disease

395

2869

1.40

8.98

1.2

1.1

10.12

1.29

u/ml

—

Retention of urine

788

5066

1.27

8.91

1.1

1.84

6.79

u/ml

0.60

Other disorders of binocular vision

282

2.40

8.73

1.1

—

Allergic urticaria

288

1994

1.48

8.70

1.1

0.92

2.55

u/ml

—

Other disorders of cornea

286

1975

1.48

8.68

1.1

72.14

1.22

u/ml

—

Other respiratory diseases principally affecting the interstitium

425

3136

1.37

8.68

1.1

0.88

1.18

u/ml

—

Varicose veins

1695

10982

1.17

8.63

1.1

1.11

7.28

u/ml

1.15

124

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

254

3707

0.68

8.60

1.1

1.14

7.63

u/ml

—

Other disorders of nervous system

186

1175

1.62

8.59

1.2

1.1

—

1.39

u/ml

—

Other fall from one level to another

701

5550

1.28

8.57

1.2

1.1

0.88

12.31

u/ml

—

Other congenital malformations, including avohilmo

457

3435

1.36

8.41

1.2

1.28

3.32

u/ml

—

Septicaemia

1161

8838

1.21

8.38

1.1

15.85

8.27

u/ml

0.21

Childhood allergy (age < 16)

653

4241

1.29

8.32

1.2

2.52

14.39

u/ml

—

Iridocyclitis

637

5007

1.29

8.31

1.1

0.96

8.75

u/ml

—

Psoriatic arthropathies, ICD10

302

2126

1.45

8.30

1.1

1.27

0.86

u/ml

—

Open wound of ankle and foot

304

2142

1.45

8.29

1.2

1.1

47.60

2.50

u/ml

—

Otitis externa, unspecified

361

2622

1.40

8.28

1.2

1.1

14.40

1.17

u/ml

—

Gastric ulcer

396

2911

1.38

8.27

1.1

35.70

1.81

u/ml

—

Other psoriatic arthropathies

294

2062

1.46

8.25

1.1

1.27

0.86

u/ml

—

Other viral diseases, not elsewhere classified

606

4727

1.30

8.24

1.2

3.82

9.59

u/ml

0.35

Injury of muscle and tendon at shoulder and upper arm level

902

7377

1.23

8.22

1.1

0.97

10.15

u/ml

—

Other septicaemia, including avohilmo

1040

8098

1.22

8.10

1.1

14.93

8.92

u/ml

0.17

Ascites

186

1192

1.59

8.06

1.1

1.23

1.93

u/ml

—

Other infectious diseases, including avohilmo

243

1653

1.50

7.99

1.1

55.40

1.39

u/ml

—

Cerebrovascular diseases

1985

12015

1.15

7.92

1.1

29.75

4.35

u/ml

0.66

146

Retinal detachments and breaks

901

7411

1.23

7.78

1.1

1.17

8.43

u/ml

—

Degeneration of macula and posterior pole

1214

7902

1.19

7.69

1.1

1.30

4.09

u/ml

0.55

ILD, hospital admissions

359

2635

1.38

7.67

1.1

0.88

1.21

u/ml

—

Myopia

439

3328

1.34

7.65

1.2

1.1

58.62

2.08

u/ml

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

123

726

1.76

7.56

1.2

1.1

—

0.99

—

Nontoxic goitre/thyroid nodule

851

6992

1.23

7.53

1.1

1.88

1.61

u/ml

0.12

Other interstitial pulmonary diseases

360

2658

1.37

7.42

1.1

0.88

1.21

u/ml

—

Interstitial lung disease

360

2658

1.37

7.42

1.1

0.88

1.21

u/ml

—

Interstitial lung disease endpoints

360

2658

1.37

7.42

1.1

0.88

1.21

u/ml

—

Other predominantly sexually transmitted diseases, not elsewhere classified

564

4438

1.29

7.42

1.2

1.1

29.23

2.26

u/ml

—

Other septicaemia

1007

7927

1.21

7.39

1.1

17.02

8.65

u/ml

0.22

Urolithiasis

771

6278

1.24

7.37

1.1

27.13

11.31

u/ml

—

Car occupant injured in other and unspecified transport accidents

574

4529

1.28

7.35

1.1

2.50

9.10

u/ml

—

Chondropathies

451

3454

1.33

7.30

1.1

1.25

2.36

u/ml

—

Herpesviral [herpes simplex] infections

354

2625

1.37

7.19

1.1

—

2.32

—

Combinations of oral blood glucose lowering drugs

678

5464

1.25

7.17

1.1

2.05

7.41

u/ml

—

Other infectious diseases

197

1315

1.53

7.16

1.2

1.1

66.32

1.59

u/ml

—

Calculus of kidney and ureter

720

5851

1.24

7.05

1.1

27.12

11.66

u/ml

—

Appendectomy

2047

17243

1.14

6.99

1.1

9.80

8.87

u/ml

0.04

204

All influenza (not pneumonia)

420

3208

1.33

6.92

1.1

37.32

11.50

u/ml

—

Myocardial infarction, without ST-elevation

868

6486

1.22

6.91

1.1

1.09

9.53

u/ml

0.91

Sensorineural hearing loss

2067

12177

1.14

6.87

1.1

1.57

7.76

u/ml

1.17

147

Acute and transient psychotic disorders

328

2422

1.38

6.85

1.1

1.32

15.41

u/ml

—

Nontoxic multinodular goitre

545

4314

1.28

6.84

1.1

1.07

1.82

u/ml

—

Benign neoplasm: Adrenal gland

214

1471

1.49

6.79

1.1

—

1.34

—

Dementia in Alzheimer disease

189

2335

0.67

6.79

1.1

0.99

1.02

u/ml

—

Acute suppurative otitis media

944

7373

1.21

6.78

1.2

1.1

8.38

10.95

u/ml

0.15

Other endocrine disorders

234

1574

1.47

6.77

1.2

—

35.15

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1954

13417

1.14

6.68

1.1

17.21

5.48

u/ml

0.50

171

Polyarthritis, unspecified

105

615

1.76

6.64

1.1

—

2.18

—

Laparoscopic right hemicolectomy

152

979

1.59

6.60

1.1

—

2.05

—

Other and unspecified iridocyclitis

146

934

1.61

6.55

1.1

—

0.90

—

Problems related to lifestyle

289

2107

1.39

6.54

1.1

0.98

15.52

u/ml

—

Acute alcohol intoxication, ICD10

535

4250

1.27

6.51

1.2

1.1

1.36

15.06

u/ml

—

Early onset COPD

529

4200

1.27

6.46

1.1

56.18

7.35

u/ml

—

Acute nasopharyngitis (common cold)

310

2272

1.37

6.44

1.2

1.1

66.08

5.32

u/ml

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

4.26

6.43

1.3

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

696

5708

1.23

6.38

1.2

1.1

18.93

8.23

u/ml

0.24

Dermatophytosis

361

2734

1.34

6.38

1.1

2.27

0.93

u/ml

—

Anomalies of dental arch relationship, including avohilmo

695

5148

1.24

6.38

1.2

1.65

3.13

u/ml

0.71

Other/unspecified enthesopathies, not elsewhere classified

207

1433

1.47

6.31

1.1

0.90

2.08

u/ml

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Tissue transglutaminase IgG Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS